IAN Textbook of Neurology Arabinda Mukherjee
INDEX
Page numbers followed by f refer to figure, fc refer to flowchart, t refer to table, b refer to box.
A
Abetalipoproteinemia 376
Abscess 104, 482
pyogenic 849
tuberculous 85f
Abulia 547
Acalculia 540
Aceruloplasminemia 573
Acetaminophen 28, 51, 758
Acetylation 810
Acetylcholine 362
receptor 633
deficiency, primary 633
system 865fc
Acetylcholinesterase inhibitors 542, 627
Acetylsalicylic acid 28
overuse headache 51
Acid maltase deficiency 637, 639, 641, 665
Acidemias, propionic 573
Acinetobacter baumannii 76
Acquired immunodeficiency
syndrome 42, 232, 604, 849
virus 442
Acrylamide 606, 774, 776, 778
Acupuncture 30
Acute inflammatory demyelinating
polyneuropathy 736
polyradiculoneuropathy 588
Acyclovir 865
Acylcarnitine 661, 661t
Acyl-coenzyme A dehydrogenase deficiency 661, 667
medium-chain 661b
multiple 661b
short-chain 661b
very long-chain 661
Addenbrooke's cognitive examination 492, 548
Addison's disease 577
Addison's syndrome 571
Adenoma, pituitary 41
Adenosine triphosphate 142, 662f, 697
Adrenoleukodystrophy 577, 582
X-linked 573
Adrenomyeloneuropathy 577, 594
Adult neural stem cells 165
Adult polyglucosan disease 573, 580
Adult-onset inherited metabolic disorder, classification of 573
Advanced glycation end products 529
Aedes aegypti 98
Agitation 526, 547
Agnosia, visual 547
Agraphia 508, 540, 547
Airway, assessment of 131
Akathisia 867
Akinesia 342
Akinetic rigid syndrome 308, 341
Albuminuria 74
Alcohol 10, 11, 278, 577, 590, 752, 753, 766, 768, 777, 778, 781, 864
abuse 516
intoxication, acute 369, 478
myelopathy 771
Alexia 508, 547
Alien limb 310
Allodynia 6
Almotriptan 20
Alogliptine 317
Alprazolam 354
Alteplase thrombolysis 127
Aluminum 577, 752
encephalopathy 229
Alzheimer's dementia 541, 684, 789, 820
Alzheimer's disease 214, 310, 330, 333, 495, 498f, 515, 516, 519, 520, 532534, 538543, 545, 547, 551, 558, 561, 564, 571, 577, 812, 813, 853f
frontal variant of 540
Amantadine 865
American Speech-Language-Hearing Association 507
Amino acid
disorders 579t
metabolism, disorders of 573
Aminocaproic acid 781
Aminoglycoside 75, 76, 752
antibiotics 864
Aminophenol derivatives 866
Amiodarone 11, 725, 754, 775, 781, 864, 868
Amisulpride 384
Amitriptyline 20, 21, 29, 65, 74, 865, 868
Amnesia 547
Amoxapine 384
Amphetamine 865
toxicity 74
Amphiphilic drug myopathy 783
Amphotericin 865, 868
B 752
deoxycholate 105
lipid complex 105
Ampicillin 75, 76
Amyl nitrate 11
Amyloid 726
hypothesis 539
precursor protein 539
Amyloidosis 589, 590, 620, 621, 639, 731
Amyotrophic lateral sclerosis 554, 555, 672, 684, 681, 683, 683t, 685, 698, 813, 820
plus phenotypes 684
Amyotrophy, monomelic 686
Analgesics 865
Ancillary
blood tests 483, 484
diagnostic tests 288
Andersen disease 664, 665
Aneurysm 41
Angiitis, primary 50
Angioedema 65
Angioma
cavernous 50
venous 42
Angioplasty, vertebral 50
Angiotensin
converting enzyme 127, 132, 147, 615, 622
receptor blockers 21
Angular gyrus 505, 506
Aniline 11
Anorexia 65
Anterior spinal artery 486
Antiangiogenesis agents 766, 768, 772
Antiarrhythmics 867
Antibodies
against postsynaptic antigen 402
against presynaptic antigen 402
anti-amphiphysin 482
monoclonal 826
muscle-specific 657
muscle-associated 657, 658
Antibiotics 358, 782, 867
Anticancer drugs 766, 768, 770
Anticholinergic 865
agents 758
toxicity 74
Anticoagulant 752, 782, 865, 868
Antidepressants 384, 864, 865, 867
Antiepileptic 21
drug 137, 188, 196, 201, 207, 213, 220, 223, 224, 226, 227, 229, 245, 249, 251, 261, 261t, 358, 405
types of 248
Antifungal
agents 104, 105, 105t, 782
therapy 107
treatment 107, 110, 111
Antigen presenting cells 442
Antihistamines 379, 866
Antimetabolites 867
Antimicrobial therapy 75
Antimicrotubular drug myopathy 784
Antineoplastics 867
Antineutrophil cytoplasmic antibody 147, 148
Antinuclear antibody 147
Antiparkinson drugs 865
Antiphospholipid antibody 229, 338, 483, 484
Antiphospholipid antibody (APLA) syndrome 229, 230f, 335, 483, 484
Antipsychotics 867
Antiretroviral
drugs 232
nucleoside reverse-transcriptase inhibitor 784
therapy 107
Antituberculosis therapy 82
Antivoltage-gated potassium channel 92, 568
Anxiety 298, 302, 315, 568, 837
Aortic stenosis 132
Apathy 302, 315, 547
Apgar score 201
Aphasia 504, 506f, 507, 511, 511t, 513, 513t, 520
anatomical substrate of 505f
assessment, methods of 507t
conduction 508, 547
natural recovery of 511
primary progressive 506, 506t, 553, 555
profound 486
rehabilitation of 511
therapy, constraint-induced 512
types of 508
Apocrine glands 581f
Apoplexy, pituitary 4, 50, 141, 143
Apoptosis 696
Appetite 79
Apraxia 520, 547
constructional 547
Arachnoiditis
optochiasmatic 80
tuberculous 78
Archimedes’ spiral 358, 359f
Arcuate fasciculus 505
Areflexia 486
Arginase deficiency 573, 579
Argyll Robertson pupil 620
Aripazine 134t
Aripiprazole 384
Arnold-Chiari malformation 67
Arreflexia 374
Arsenic 11, 577, 605, 752, 753, 758, 774776
Arterial dissection, intracranial 50, 141
Arteriosclerotic encephalopathy
subacute 476f
subcortical 529
Arthralgia 21, 65
Arthritis 74
rheumatoid 231, 589, 590, 630
Articulation 507
Asenapine 384
Ashworth scales 799, 800t
modified 800t
Aspergillosis 104, 109f, 110f
Aspergillus fumigatus 233
Aspiration pneumonia 74, 337
Aspirin 28, 128
Asymmetric tonic limb posturing 240
Ataxia 65, 334, 344, 368, 371, 372, 375, 376, 449, 486, 594
autosomal recessive 376t
classification of 371
episodic 179, 375
frontal 371
hereditary 375t, 594
neuropathy syndromes 669
nonvertiginous 369
signs of 369
spinocerebellar 372, 376, 594, 669
symptoms 369
distribution of 372
telangiectasia 376, 594
types of 368, 369t
Ataxic hemiparesis 121
Atenolol 354
Athetosis 342
Atrophy 506
multisystem 307, 308, 311, 312f, 313, 342
Atropine 11
Attention deficit hyperactivity disorder 429
Auditory
comprehension 507
cortex, primary 237, 505
phonological analysis 510
Aura 17
autonomic 238
gustatory 238
olfactory 238
painful 236
psychic 238
typical 17
vertiginous 238
visual 237
Autism 816, 839, 859, 860f
Autism spectrum disorder 839, 841
Autoantibodies 525, 568t, 569t
Autoimmune encephalitis 577
paraneoplastic 577
nonparaneoplastic 577
Autonomic
dysfunction 284, 302, 303, 370, 374, 559, 560, 620t, 625
failure, pure 623
function tests 371, 623, 623t
ganglionopathy, autoimmune 620, 621
nervous system 870, 872
neuropathy 590, 593, 599, 605, 619
causes of 622t
pharmacology 215
Autosomal dominant 575, 594, 669
dystonia 347
epilepsy 173
limb girdle muscular dystrophy 710
muscular dystrophies 708
mutations 539
Axial dystonic events 183
Axillary skin biopsy 581f
Axonal Charcot-Marie-tooth disease 596
Axonolysis 727f
Azathioprine 459, 460, 631
Aztreonam 76
B
B cells 442
Baclofen 303, 405, 803
Ballismus 395
etiology of 395, 396
pathophysiology of 395
treatment of 398
types of 395, 397
Barbital withdrawal seizures 862
Barbiturates 374, 758, 866
Barium 781b
Basal ganglia 396f, 676f, 768
Basilar skull fracture 75
Becker muscular dystrophy 635, 639, 643, 708, 709f, 743, 746
Behçet's disease 148, 230, 335, 484, 516, 569
Benign paroxysmal tonic upward gaze 185t
Benzamides 384
Benzisothiazole 384
Benzisoxazole 384
Benzodiazepines 211, 380, 401, 403, 405, 526, 758, 803, 828, 865
Benztropine 865
Berry aneurysm 141
Bethlem myopathy 638, 648
Betz cells 768
Biballismus, causes of 397
Bickerstaff's brainstem encephalitis 609
Bifidobacterium 838, 839
Bimelic amyotrophy 686, 689f
distal 686, 690f
proximal 686
proximodistal 686
Binswanger's disease 463, 476, 476f, 478, 480, 529
Biopterin deficiency 207b
Blastomyces dermatitidis 105
Blastomycosis 104
Blepharospasm 363
management of 363
Blindness, cortical 486, 547
Blink reflex 737, 737f
Blood 126, 749
borne substances 823
brain barrier 104, 188, 454, 749
disruption of 829
count 591
complete 570, 615
dyscrasias 65
glucose 525
fasting 615
pressure 132, 623
control of 126
diastolic 126
management of 132
systolic 126
Bone
dysplasia 639
health 224
marrow
derived cells 165
suppression 105
pain 99
Borrelia burgdorferi 448
Botulinum
neurotoxin 362, 363, 805f
toxin 351, 361, 362f, 363, 366, 405
toxin injections 362
types of 351t
use of 361
Bouncy gait 342
Braak hypothesis 314
Brachial monomelic amyotrophy 686, 687f, 688f
Bradycardia 21
Bradykinesia 284, 285, 344, 374
Brain 870
abscess 56, 71, 74
tuberculous 78
aging, pathobiology of 528
biopsy 582f
capillary transcytosis, receptor mediated 826f
cortex of 582f
derived neurotrophic factor 189, 525
development, effect on 840
embolism, cardiogenic 871
infarction 871
injury 330, 797
traumatic 277, 793, 821
iron accumulation 574, 582
spectrum 573
neurotransmitters 215
stem 486
stimulation
noninvasive 512
role of noninvasive 166
techniques 873
tissue 823f
tumor 125, 516
cortical 208
Brainstem 870
aura 17
cavernous hemangioma 42
infarction 42
normal 835f
syndrome, acute 455
auditory evoked potential 834
encephalitis 482
lesions 74
Brancher enzyme deficiency 665
Breastfeeding 223
Breath holding spells 185
Breathing, assessment of 31
British Medical Council Severity Grading of Tuberculous Meningitis, modified 80
Broca's aphasia 508, 547
Broca's area 505
Bromate 11
Bromocriptine 380
Bromperidol 865
Bronchospasm 21
Brucellosis 567, 604
Brudzinski's signs 72
Bulbar muscular atrophy 698
Bulbar palsy, progressive 672, 682f
Bupropion 867
Butyrophenones 384
C
Cabergoline 380
Caffeine 10, 11, 28
Calcitonin gene-related peptide monoclonal antibodies 22
Calcium 677
carbide 868
channel blocker 132, 384, 867
Calpainopathy 713
Camphor 11
Campylobacter jejuni 587, 837
infection 837
Cancer
control of 162
prevention of 162
Candesartan 21
Candida 577
Candidiasis 104, 232
Cannabis 752
Carbamates 752
Carbamazepine 65, 211, 216, 227, 261, 380, 752, 864, 865
Carbapenems 867
Carbon
disulphide 11, 606, 774
monoxide 473, 474, 752, 753, 756
tetrachloride 11
Carbutamide 868
Carcinoid syndrome 179
Cardio-aortic embolism 117
Cardioembolism 116, 121
Cardiomyopathy, dilated 651
Cardiovascular disease 483
control of 162
prevention of 162
Cardiovascular disorder, drug-induced 863
Carnitine
deficiency 65, 641, 667, 720, 721f
transporter 666
deficiency 667
Carotid sinus hypersensitivity 179t
Carotid artery
atherosclerosis of 871
stenosis 120
revascularization 122
Carpal tunnel syndrome 591
Caspofungin 105
Cassava poisoning 766, 768
Cataplexy 179
Catastrophic epilepsy syndromes 202
Catatonia 524, 864
Catechol-O-methyl transferase 291, 300
Cauda-equina syndrome 486
Cavernous sinus 42
meningioma 41
Cefepime 76
Cefotaxime 75, 76
Ceftazidime 76
Ceftriaxazone 76
Ceftriaxone 75, 76
Celiac disease 231, 620
Central core disease 639, 717, 718f
Central nervous system 4, 50, 88, 93, 96, 103, 103fc, 104t, 200, 226, 232, 319, 333, 368, 378, 444, 448, 450, 463,567, 573, 790, 799fc, 811, 824, 824f
aspergillosis 108, 110
disease, stress-related 837
drug delivery 824
fungal infections 105
hemorrhage 232
infection 478
lymphoma 478, 483
primary 232, 482
mucormycosis 110, 111
neoplasm 564
secondary angiitis of 50
tuberculosis 78, 86
classification of 78
drug-resistant 86
vasculitis 463, 477, 483, 564, 569
Central pontine
demyelination 441
myelinolysis 466, 467f, 479, 482
Central skull base, destruction of 109f
Centrum medianum 396
Cephalosporin 468, 867
third generation 75, 76
Cerebellar
abscess 373
artery
posterior 121
superior 42, 121
ataxia 371, 373t, 375, 376, 821
episodic 375
hereditary 816
degeneration, paraneoplastic 568
disorders 864
examination 751
fits 179
hemisphere 42
mutism 371
speech 370
stimulation 257
syndrome 762
drug-induced 863
Cerebellopontine angle
arteriovenous malformation 42
tumor 67
Cerebellum 486
Cerebral
amyloid angiopathy 478
arterial imaging 149
aspergillosis 109
autosomal dominant
arteriopathy 50, 52, 147, 476, 477f, 480, 482, 483
subcortical ischemic leukoencephalopathy 463
cortex 395, 558
edema 153
fat embolism 74
hemorrhage, drug-induced 863
imaging 525
infarction 49
insufficiency 864
ischemia 115, 141, 144, 826
postnatal 203
malaria 74
malformations 203
mass lesions 104
palsy 372, 794, 797, 859
peduncles 676f
perfusion pressure 142
vasculitis, drug-induced 863
Cerebral venous thrombosis 4, 50, 52, 143, 148, 152, 156t, 478
Cerebritis 482
Cerebrospinal fluid 45, 54, 57, 66, 71, 79, 90, 96, 104, 141, 201, 404, 450, 454, 458, 463, 480, 483, 484, 529, 542, 565, 569, 570, 591, 622, 672, 744, 848
analysis 80
biomarkers 542
cell response 104
circulatory physiology 529
examination 525, 615
lymphocytosis 50, 57
oligoclonal bands 484
pressure 26, 50, 54
protein 611
shunt 75
spontaneous 54
Cerebrotendinous xanthomatosis 580, 582
Cerebrovascular
accident 396
disease 789, 843, 862, 863t
disorders 234
drug-induced 863
Ceruloplasmin, serum 322
Cervical
artery dissection 4, 143
compressive myelopathy 478
dystonia 364
flexion induced myelopathy 686
ganglia, superior 870
meningioma 41
spinal cord infarction 41
Charcot joints 600
Charcot-Marie-tooth disease 589, 590, 593596, 597t, 599t, 601, 612, 725, 730, 731, 743, 745, 745fc
classification of 743t
demyelinating 595
subclassification of 595t
types of 731t
X-linked 596
Chemotherapeutic drug 478
Chemotherapy 482
Chiari malformation 50, 54, 179
Chikungunya 96, 100, 101
virus 100
Childhood occipital epilepsy, late onset 173, 207
Chinese ischemic stroke subclassification 118
Chlamydia 448
Chlorambucil 867, 868
Chloramphenicol 75, 76, 868
Chlorate 11
Chlorophenoxy herbicides 781
Chloroquine 781, 868
Chlorpromazine 384, 865, 867
Chlorpropamide 758, 868
Chlorprothixene 384
Cholesterol 440
cyst 42
Choline acetyltransferase deficiency 633
Chorea 280, 334, 335fc, 338, 342344, 374, 433, 867
acanthocytosis 338
acute 425
autoimmune 281
causes of 334
drug-induced 339
functional 411
gravidarum 338
Choreiform dyskinesias
biphasic 300
peak dose 299
Choroid plexitis 233f
Chronic inflammatory demyelinating polyneuropathy 588, 603, 606, 610, 613, 616, 728, 729f
Chronic obstructive airway disease 33
Churg-Strauss syndrome 589
Ciguatoxin 781
Cinnarizine 384
Ciprofloxacin 76, 865
Circle of Willis 41
Cirrhosis, decompensated 326
Cisplatin 606, 752, 753, 779, 868
Clarithromycin 864
Clebopride 384
Clioquinol 482, 766, 768, 769, 868
Clobazam 211, 227, 261
Clofibrate 781, 868
Clomipramine 29
Clonazepam 211, 227, 262, 303, 354, 380, 403, 405
Clonidine 303, 380, 803
Clordecone 11
Clostridium botulinum 361
Clostridium perfringens 454
Clostridium sporogenes 839
Clozapine 312, 384, 865, 867
Clumsy hand dysarthria syndrome 121
Cluster headache, secondary 41
Coagulation disorders 141
Cobalamin 516
Cocaine 11, 74, 474, 752, 756
abuse 141
Coccidioides immitis 105
Cognitive
impairment 247, 297, 315, 862, 864
mild 433
subcortical 486
neuropsychology 512t
Cognitive enhancement terminology 876fc
Colchine 781
Cold stimulus 46
Collagen vascular disease 41
Colloid cyst 179
Colloidal drug carriers 826
Coma 79
Combined degeneration, subacute 470, 478, 479
Complex regional pain syndrome 67
Composite autonomic severity score 624
Compound muscle action potential 674, 690, 735f
Computed tomography 118, 552, 622
angiography 480
brain 324f
venogram 154
Concomitant persistent facial pain 63
Conduction velocity 594
Confusion 79
assessment method 525
Congenital muscular dystrophies, subtypes of 714t
Fukutin and Merosin deficient 638
Conjunctival injection 8, 9, 31, 33, 34, 36, 38, 40, 42
Connective tissue 590, 612
Consciousness 79, 179
Consolidation therapy 107
Contraception 221
emergency 221
Conus medullaris syndrome 769
Convulsive status epilepticus 74
Copeptin 525
Copper 11, 607
deficiency myelopathy 478
Cori-Forbes disease 664, 665
Corneal
confocal microscopy 623
reflex 183
Coronary artery disease 119
Coronavirus 448
Corpus callosum, splenium of 356f
Cortex 768
Cortical
atrophy, posterior 516, 519, 540
dysplasia, focal 189, 257
myoclonus, treatment of 333fc
Corticobasal
degeneration 307309, 516, 313, 519, 520, 564
syndrome 286, 288, 310, 310f
diagnosis of 310
Corticobulbar syndromes 678
Corticospinal tract 470, 674
Corticosteroids 82, 92, 781, 631
intravenous 459
Cortisol 525
Corynebacterium diphtheriae 776
Cramps 781
Cranial
autonomic symptoms 31, 38f
bone, disorder of 56
disorder 14, 49
functional movement disorders 411
nerve 594
examination 588, 751
palsies 79, 449, 589
neuropathies, painful 14
Craniectomy 135
Craniocervical dystonia 56
Craniotomy 49, 135
trials 135
Cranium, disorder of 59
C-reactive protein 525, 615
Creatine
deficiency syndromes 204
kinase 644, 651
phosphokinase 702, 783
Creutzfeldt-Jakob disease 330, 333, 520, 542, 564, 565, 577
Creutzfeldt-Jakob disease, sporadic 565f, 566f
Cryoglobulinemias 147
Cryoglobulins, serum 615
Cryptococcal
antigen 570
immune reconstitution inflammatory syndrome 108
meningitis 57, 105, 233f
meningoencephalitis 107
Cryptococcomas 106
Cryptococcosis 104
Cryptococcus gattii 106
Cryptococcus neoformans 103, 106, 233
Cryptogenic stroke, evaluation of 118fc
Culex tritaeniorhynchus 96
Cushing's syndrome 516, 571
Cyanide 752
Cyclic adenosine monophosphate 866
Cyclooxygenase 190, 278
negative fibers 707f, 721f
Cyclosporine 474, 781, 864
Cysticercosis 482
Cysts, subcortical 579
Cytarabine 868
Cytokines 525
Cytology 570
Cytomegalovirus 88, 232, 448, 577, 603
Cytopathy, mitochondrial 482
Cytosine arabinoside 577, 775
D
da Vinci surgical system 860
Dalaka's criteria, modified 403
Dance intervention 292
Danon disease 666
Dantrolene 405, 803
Dapsone 590, 606, 754, 776, 868
Daptomycin 76
Debrancher deficiency 641, 665
Deep brain stimulation 36, 257, 292, 300, 301, 301t, 339, 350, 351, 354, 415, 416, 419, 435
programming 417
Deep vein thrombosis 131
treatment of 129
Dejerine-Sottas syndrome 595
Delirium 486, 522, 524526, 547, 862, 864, 865
assessment scale 525
biomarkers of 525
index 525
pathophysiology of 523
subtypes of 524t
symptom interview 525
treatment of 526
Delusion 315, 864
Dementia 33, 287, 302, 308, 311, 312, 374, 495, 515517, 519, 519t, 520, 532, 558562, 564, 573, 583fc, 859, 864
causes of 515, 516
classification of 516
degenerative 564, 577
diagnosis of 311
mimics 518
mitochondrial 575, 577t
multi-infarct 547
neurodegenerative 495
rapidly progressive 564, 570t
subcortical 433
subtypes 546
syndromes, classification of 515
Demerol 867
Demyelinating disease, acute 482
Demyelination 440, 516, 729f
disorders 843, 846
infectious 74
nutrition associated 466
post-infectious 74
types of 441
vasculitis-associated 478f
Dendritic cells 442
Dengue 96, 98, 99, 101
encephalitis 99
encephalopathy 99
fever 99
hemorrhagic fever 99, 99f
neurological manifestations of 99
shock syndrome 99
virus 98
infection 99t
Deoxyribonucleic acid 88, 147, 528, 570, 710, 809, 811f
methylation 811, 812
Depot medroxyprogesterone acetate 221
Depression 65, 298, 302, 326, 371, 571, 576, 838, 864
Dermatomyositis 654, 655, 658, 659t, 704, 707
extramuscular manifestations of 655
juvenile 638
treatment of 659
Descemet's membrane 322f
Desipramine 865
Desminopathy 641
Dexamethasone 75
role of 77
Diabetes 590
control of 162
mellitus 232, 378, 402, 602, 621
prevention of 162
Diabetic autonomic neuropathy 602
Diabetic neuropathy, modified classification of 602t
Dialysis disequilibrium syndrome 229
Diamines 868
Diazepam 227, 403, 405
Dibenzazepine 384
Dibenzodiazepine 384
Diclofenac 28
Didanosine 868
Diethylene glycol 758
Diffuse toxic encephalopathy, acute 761
DiGeorge syndrome 231
Digitalis 11
Digoxin 758
Dihydroergotamine 35
Diltiazem 867
Diphenylbutylpiperidine 384
Diphtheria 448, 754, 776
toxin 775, 777, 778
Diplopia 65
Dipyridamole 11
Disability adjusted life years 124, 196, 789
Disopyramide 868
Disseminated encephalomyelitis, acute 441, 448, 448t, 449t, 450, 450t, 463, 464, 464f, 478, 479, 484, 485
Disseminated intravascular coagulation 74
Disulfiram 11, 868
Dizziness 21, 65, 179
Domperidone 313
Donepezil 312, 865
Doose syndrome 206
Dopamine
agonists 290, 298, 300, 865, 868
antagonists 379
receptor
blocking agents 387
hypersensitivity 384
storage imaging 850
transporter imaging 312, 850
Dopaminergic system 852f
Dorsal root ganglia 619
ganglionopathy 605
Doxepin 29
Dravet syndrome 173, 177, 203, 211
Drop attacks 179, 255
Drowsiness 21, 486
Droxidopa 313
Drugs 516
abuse 516, 863
antiepileptic 211
anti-inflammatory 865
antiseizure 137
antituberculous 85t
behavioral toxicity of 864
blood level of 570
cardiac 782
immunosuppressive 782
reactions, acute 423
resistant epilepsy 187, 188f, 251253, 255f
diagnosis of 252
mechanisms of 188
toxicity 232
Dry mouth 21
Duchenne muscular dystrophy 635, 639, 642, 643, 643f, 708, 709f, 742, 745, 746, 746fc
Duloxetine 65
Dysarthria 65, 370, 433, 638, 669
Dysdiadochokinesia 370
Dysferlin, loss of 712f
Dyskinesias 299, 342, 374, 415, 422
levodopa-induced 300
Dysmetria 369
Dysmyelination 440
Dysphagia 299, 370, 374, 433, 652
severe 682f
Dysreflexia, autonomic 56
Dysthyroid ophthalmopathy 638
Dystonia 97, 279, 326, 342, 343, 346, 347, 348, 364, 374, 409, 433
acquired 349
acute 349, 423
chronic 868
classification of 351t
drugs induced 349
functional 410
musculorum deformans 346
parkinsonism, rapid onset 348
peak dose 300
plus syndromes 346
posthypoxic 350
poststroke 350
post-traumatic 350
prevention, drugs induced 349
primary 279, 346
secondary 280, 349
segmental 580f
surgical therapy of 351
treatment of 351
types of 350
Dystonic
limb, painful 303
reactions
acute 868
drug-induced 868
syndrome 322
Dystroglycanopathy 639, 649
Dystrophin-associated proteins 642
Dystrophin protein complex 642f
Dystrophinopathy 639, 641
Dystrophy 635
classification of 708t
muscular 642, 704, 816
myotonic 639642, 650, 713
neuroaxonal 725
E
Eagle's syndrome 67
Ecchymotic skin lesion 99f
Eclampsia 56
Ecstasy 756
intoxication 74
Electrical stimulation 166
functional 795
Electrocardiogram 525, 561
Electroclinical syndromes 200, 201
Electrocorticography 189, 256
Electrodiagnostic tests 181, 590
Electroencephalogram 90, 97, 173, 179, 189, 200, 205, 229, 254, 373, 466, 519, 525, 565, 570
abnormal 196
Electrolyte 525, 755
disturbances 105
Electromyography 308, 404, 684, 702, 734
quantitative 831
Electron transport chain 666f
Electroneuromyography 678, 734
Electrophoresis, immunofixation 615
Electrophysiology 412, 596, 690, 734, 753
Eletriptan 20
Emery-Dreifuss muscular dystrophy 637, 638, 641, 646, 648, 649, 708, 711f
Emetine 781
Emotional facial asymmetry 241
Empirical antimicrobial therapy 75
Empyema
epidural 74
subdural 56
Enalaprilat 132
Encephalitis 56, 74, 232, 568
arboviral 96
autoimmune 93, 478, 516, 564, 567, 569
limbic 482
neonatal 93
paraneoplastic 569
Encephalitis lethargica 423
Encephalomyelitis
acute hemorrhagic 450
paraneoplastic 568
progressive 401
Encephalomyopathy, mitochondrial 147, 482, 575, 716
Encephalopathy 333, 486, 669
epileptic 173, 202
hepatic 326, 516
hyperammonemic 65
hypertensive 56
hypoxic ischemic 463
metabolic 125, 478
mitochondrial 50, 185, 190, 478, 638
myoclonic 173
neurogastrointestinal 669
sepsis-associated 74
steroid responsive 373
thyrotoxic 74
tuberculous 78
Endemic fluorosis 767f
Endocarditis 74
bacterial 335, 871
Endocrine 516, 590
disorders 231, 334
myopathies 636, 704
Endocrinopathy 571, 615, 620
Endomysial inflammatory cell infiltrate 705f
Endomysium 733f
Endothelial growth factor 826
Endplate acetylcholinesterase deficiency 633
End-stage liver disease 323
Enterobacteriaceae 71
Enterovirus 692
Entorhinal cortex 531f
Enzyme
activity 755
histochemistry 704
inducibility 215
linked immunosorbent assay 569, 570
Eosinophilic cell response 104
Epididymitis 74
Epidural anesthetic agents 766, 768, 769
Epigenetics, role of 809
Epigenomics 809
Epilepsia partialis continua 152, 329
Epilepsy 173, 176179, 182, 193, 196, 200, 205, 207, 208, 211, 213, 214, 217, 220, 221, 224, 245247, 261, 261t, 374, 375, 669, 789, 813, 820, 843, 847
annual incidence rate of 195t
autoimmune 209
benign 173, 178
burden of 245f
catamenial 220
childhood absence 173, 178, 206, 332
classification 171, 172, 172t, 178
etiology of 195
familial
focal 173
infantile 392
temporal lobe 173
focal 176, 207, 211
gender distribution of 194
generalized 177, 206
incidence of 194
menstrual 205
mortality of 194
myoclonic 173, 207, 330, 575, 669
occipital lobe 209
operational classification 174fc
partialis continua 333
photosensitive 206, 207
prevalence of 193, 194t, 195t
reading 206, 207
remote symptomatic 214
Rolandic 211
surgery 247, 252, 253, 258
burden of 252
syndrome 177, 201, 205, 206, 211, 211t, 330
benign 201
childhood-onset 206
classical 200
nature of 248
treatment 193
gaps of 196t
Epileptogenesis 187, 189, 190, 190f
molecular mechanisms of 189
Epileptogenic focus, location of 248
Epsilon-Sarcoglycan gene mutations 348
Epstein-Barr virus 42, 88, 444, 448, 603
Ergotamine 866, 868
Erythema nodosum leprosum treatment 605
Erythrityl tetranitrate 11
Escherichia coli 71, 75, 76
Esmolol 132
Estrogen 11, 278
Ethambutol 752, 754, 868
Ethanol 755, 781
Ethionamide 868
Ethoglucid 868
Ethosuximide 211, 262
Ethyl alcohol 776
Ethylene
glycol 753, 756, 758, 778
oxide 606, 774
Ethylenediaminetetraacetic acid 11, 746
Expanded disability status scale 457
Extractable nuclear antigen antibodies 615
Extrapyramidal symptoms 65
Eyelid
edema 9,33, 36, 38, 40
myoclonia 206
Eye movement 120, 172, 179, 184
assessment of 120
non-rapid 179t,184t
rapid 179t,184t
abnormality 120
F
Fabry's disease 147, 148, 588, 590, 594, 620, 725
Facial
movement disorders, functional 411
myokymia 486
numbness 486
pain 14, 50, 56, 59, 63, 64, 65t
trauma 41
weakness 589
bilateral 608
Facio-brachial dystonic seizures 568
Facioscapulohumeral dystrophy 637, 642, 649, 650f, 708, 743
Fahn-Williams diagnostic criteria 408, 408t
Fahr's disease 573, 580
Familial amyloid polyneuropathy 594b
Familial infantile epilepsy, benign 173
Familial neonatal seizures, benign 201
Fanconi anemia 576
Fasciculation 673, 677, 738f
syndromes 678
Fast-channel syndrome 633
Fat infiltration 713
Fatal hepatotoxicity 65
Fatty acid metabolism 666f
disorders of 636
Febrile seizures plus 173, 206
Felbamate 211, 262
Fenfluramine 865
Fentanyl 867
Fetal
malformations 222
neural stem cells 165
Fever 79, 99, 129, 568
causes of 74
persistent 99
secondary cause of 74
Fiber
electromyography, single 741, 831, 833f
needle electrode, single 833f
neuropathy, small 619, 620, 622f
regenerative 705f
Fibrates 781
Fibrillations 738f
Fibrinogen deposits 728
Fibrinolytic therapy 136
Fibromyalgias 378
Fibrosis 713
Fibrotic cap, thin 844
Finger agnosia 540
Flail arm syndrome 682f, 683
Flail leg syndrome 683
Fluconazole 105
Fludarabine 474
Fludrocortisone 313
Fluid attenuated inversion recovery 81, 90, 254, 464, 484, 565, 565f, 757, 577
Flunarizine 21, 384
Fluoride 758, 766, 768
Fluorodeoxyglucose 288
Fluoroquinolone 75, 76
Fluorosis 766, 768, 769
Fluoxetine 865
Flupenthixol 865
Fluphenazine 435
Flushing, forehead and facial 9, 33, 36, 38, 40
Focal hand dystonia 310f
Focal-multifocal neuropathies, causes of 589
Folic acid 590
Fragile-X tremor ataxia 355, 355t
Frenchay aphasia screening test 548
Friedreich ataxia 372, 376, 594
Froment's maneuver 285
Frontal lobe 237
epilepsy 184, 208, 249
seizures 179, 184
Frontocerebellar tracts 368
Frontotemporal dementia 309, 311, 498f, 515, 516, 519, 520, 551, 552, 554, 555, 564, 577, 684, 820
lobar degeneration 552
genetics of 555t
Frovatriptan 20
Fukuyama congenital muscular dystrophy 638, 649
Functional movement disorders 407, 411, 412
etiology 407
pathophysiology 407
management of 413
Funny gait 337
Fusion protein vectors 825
G
Gabaergic neurotransmission, role of 189
Gabapentin 65, 211, 216, 262, 380, 405, 803
Gait 751
ataxia 370, 375
disorder 307, 433
freezing of 297
impairment 409
treatment of 303
Galactocerebroside 440
Gamma aminobutyric acid 167, 348, 402f, 803
Gamma sarcoglycanopathy 713f
Gammopathy, monoclonal 610, 620
Ganglionic degeneration, cortical-basal 333
Gastaut syndrome 207
Gastric decontamination 758
Gastroenteritis, mild 202
Gastrointestinal
disturbance 15, 298, 302
recurrent 17
dysfunction 302
motility promoting drugs 384
symptoms 286, 291
system 222
Gatifloxacin 76
Gaucher's disease 279, 573, 579
juvenile 207
Gaze palsy 73t,120, 286b
supranuclear 308
vertical 308
Gene
therapy 644, 700
variant hypothesis 188f
Genetic 278, 279, 320, 546, 554, 560, 684, 743
ataxias 378
counseling 700
muscle diseases 745t
myopathy 743, 745
neuropathy 742, 744
predisposition 384
role of 190
studies 644, 677
testing 289, 323, 598, 746fc
vasculopathy 50
Genital sensations 237
Gentamicin 76
Geriatric depression scale 548
Germ cell testicular tumor 568
Gerstmann syndrome 540, 547
Geste antagoniste 343, 347
Giant cell arteritis 26, 41, 50, 110f, 516, 546, 612t
Glasgow coma scale 131, 132
Glaucoma
acute 56
worsening of 65
Glial
cell cytoplasm 439
disorders 816
fibrillary acidic protein 455
Gliomatosis cerebri 482
Global cognitive tests 548
Globus pallidus 419, 506
externa 396f
interna 396f
Glomerular filtration rate 105
Glucocerebrosidase, heterozygous 560
Glucose
hypometabolism 539
management 137
tolerance test 621, 622
transporter defect 204
Glutamate receptor
modifiers 543
role of 189
Glutamic acid decarboxylase 373, 400, 402, 569
Glutaric aciduria 667
Glutathione 541
Gluten ataxia 373
Glutethimide 868
Glyceryl trinitrate 11
Glycine encephalopathy 204
Glycogen
metabolism, disorders of 636, 662, 665
Glycogen storage disorder 639, 661, 662, 663f, 664, 665, 720, 722f, 723f
Glycogenosis, types of 637
Glycol 755
Glycoprotein
anti-myelin-associated 612
myelin-associated 615, 616
Glycosylation 648
Gower's sign 635
Grand mal epilepsy 211
Granulocytes 442
Granuloma 104
noncaseating 83
solid caseating 83
Grave's disease 630, 638
Greater occipital nerve block 21, 35, 37
Guillain-Barré syndrome 588, 589, 591, 603, 607, 608, 608t, 620, 778, 794, 862
Gupta-Lang criteria 409t
Gut microbiota 278, 837841
Gynecomastia 65, 589
H
Haemophilus influenzae 71, 75, 76
Hair testing 755
Hallucinations 65, 547, 560
Haloperidol 384, 435, 865
Hamartoma, hypothalamic 203
Hammersmith Functional Motor Scale 699
Hartnup's disease 573, 579
Harvard stroke registry 115
Hashimoto's encephalitis 569
Hashimoto's encephalopathy 231, 482, 577
Hashimoto's thyroiditis 484, 630
Hatchet facies 652
Head
injury 41
post-traumatic 51
pain 56
trauma 75
tremor 357
Headache 3, 911, 14, 26, 45, 4954, 56, 59, 74, 79, 99, 152, 366, 568, 862
acute 49
alcohol-induced 50
analgesic-overuse 51
attack 26, 34, 35, 38
frequency of 25
tension-type 25
caffeine-withdrawal 51
carbon monoxide-induced 50
cervicogenic 26, 56, 59
chronic 5
cluster 8, 31, 33
daily 54
tension type 7, 24, 25
cluster 5, 6, 10, 3135, 35t
cocaine-induced 50
cold stimulus 44, 46
combination-analgesic-overuse 51
cough 44, 45
disorders 14, 14t, 49
classification of 6, 7, 13, 17, 25, 31, 33, 36, 39, 40, 44, 51, 53, 55, 56, 63
primary 14, 44, 49
donor-induced 50
drug-induced 866
episodic cluster 8, 31, 33
ergotamine-overuse 51
estrogen-withdrawal 51
evaluation 3
exacerbation 42
external pressure 44, 46
high-altitude 56
histamine-induced 50
hypnic 7, 44, 46
infrequent tension-type 24
medication overuse 5, 11, 16, 28, 51, 5355
new daily persistent 7, 44, 47
nitric oxide donor-induced 11, 50
opioid withdrawal 51
pattern of 25
peri-ictal 237
persistent 49
post-traumatic 51
post-dural puncture 50, 54
post-endarterectomy 50
postictal 50
primary 3, 5, 8fc, 10t, 14, 44, 45
chronic daily 7t
secondary 3, 4t, 14, 49, 50, 56
sentinel 4, 143
short duration 7
tension type 5, 6, 810, 14, 15, 2426, 28, 28t, 29t, 51, 58
thunderclap 4, 44, 46, 143
transient 50
treatment of 866
triptan-overuse 51
Heart 870
disease 871
structural 214
examination of 120
failure
chronic 872
congestive 132
neural regulation of 871f
neuroanatomy of 870
neurophysiology of 870
Heat stroke 74
Heavy metals 278, 753
Heel-Shin test 368
Helicobacter pylori 840
Hemangioma, cavernous 483
Hematological test 322, 755
Hematoma
chronic subdural 125
growth 132
subdural 26, 435
Hematuria 74
Hemiballismus syndrome 121
Hemichorea 121
Hemicrania
continua 6, 7, 31, 34, 39, 40
epileptica 50
Hemicrania epileptica 50b
Hemifacial spasm 332, 364
Hemiparasthesia 449
Hemiparesis 79, 486
Hemiplegia, acute 449
Hemisensory syndrome 486
Hemogram 525
Hemorrhage 99
adrenal 74
intracerebral 4, 131, 132t, 133t, 135t, 136
anticoagulant-induced 133
antiplatelet-induced 134
management of 131, 131fc
recurrence of 138
intracranial 5, 142, 228
intraplaque 844
intraventricular 136
nontraumatic
acute subdural 49
intracerebral 49
intracranial 49
subarachnoid 49
subarachnoid 4, 5, 74, 115, 131, 141144
aneurysmal 141
nonaneurysmal 141
Heparin, reversal of 133
Hepatic failure 65, 227
acute fulminant 326
Hepatic function tests 525
Hepatitis 65
A 448
B 448
C 147
Hepatobiliary system 750
Hepatotoxicity 105
Hereditary chorea, benign 334, 338
Hereditary neuropathies
causes of 594
classification of 593fc
treatment of 600
Hereditary neuropathy with liability to pressure palsies 596,598
Hereditary sensory 590, 593, 599
neuropathy 745
Hereditary spastic paraparesis 594
Hernia 222
Heroin 474, 752, 756, 766, 768
myelopathy 771
Herpes simplex 448, 603
encephalitis 88, 101, 333, 335, 565
virus 90, 93, 232, 577
Herpes zoster 63, 232
Heterogeneous neurodegenerative syndrome 551
Heterophoria 56
Heterotropia 56
Hexacarbons 778
Hiccoughs 330
Hip abduction sign 647, 647f
Hippocampal stimulation 257
Hirayama disease 681, 686
Histamine 10
Histone
acetylation 811
acetyltransferase 191
deacetylase 191
methylation 811
Histoplasma capsulatum 105
Histoplasmosis 104
Holmes tremor 357
Homocystinuria 573
methylenetetrahydrofolate reductase deficiency 579
Homoeostasis, disorder of 14, 56, 57
Hormone
adrenocorticotropic 203, 211, 332
exogenous 11, 51
luteinizing 220
parathyroid 228
Horn cell disease, anterior 704
Horner's syndrome 620
Human embryonic stem cell 818
tumorigenicity of 818t
Human glial progenitor cells 819
Human immunodeficiency virus 42, 78, 86, 106, 106t, 107, 147, 232, 233f, 265, 278, 335, 396, 442, 448, 465f, 482, 483, 516, 564, 567, 570, 577, 590, 603, 615, 620, 622, 792
Human leukocyte antigen 455, 525
Human T-lymphotropic virus 1 484
Human umbilical cord blood cells 165
Humeroperoneal syndromes 637
Hummingbird sign 308t, 309f
Hunt and Hess grading system 142t
Huntington's disease 280, 330, 333, 334, 336, 338, 343, 344, 432, 433, 433t, 434t, 516, 813, 819
diagnosis of 337
juvenile 207
pathophysiology 432
rating scale 339
treatment 434
Hyaline body myopathy 637
Hydralazine 11, 303, 868
Hydrocephalus 26, 50, 179
Hydrocodone 380
Hydrogen sulfide 11
Hyperammonemia 65
Hypercapnia 56
Hypercholesterolemia 65
Hyper-CK-emia 635
Hyperechogenic lentiform nucleus 853
Hyperekplexia 173
Hyperglycemia
nonketotic 232
Hyperhidrosis 365
Hyperkalemic periodic paralysis 639, 720
Hyperkinetic 174
movements, non-jerky 343
syndrome 341
Hypermotor seizures 182, 241
Hypernatremia 125, 334
Hyperparathyroidism 231
Hyperpyrexia syndromes 422
Hyperreflexia 337, 374
Hypersecretory syndromes 365
Hypersomnolence 524
Hypertension 146, 863
arterial 56
intracranial 41, 50, 758
idiopathic 26
Hypertensive crisis, acute 4, 141
Hyperthermia, malignant 74, 424, 785
Hyperthyroidism 231, 334
Hypertrophic obstructive cardiomyopathy 651
Hyperventilation 179, 181
Hypobetalipoproteinemia 594
Hypocalcemia 125, 179, 214, 232, 334, 424, 516
Hypoglycemia 334
Hypokalemia 214
Hypomagnesemia 334
Hypomania 864
Hypomyelinating neuropathies, congenital 595
Hyponatremia 65, 214, 232, 334
Hypoparathyroidism 334
Hypophysitis, lymphocytic 50
Hypotension 21, 863
intracranial 50, 54
orthostatic 214, 299, 623, 624f
Hypothalamic dysfunction 179, 185
Hypothyroidism 56, 65, 231, 378, 516, 590, 639
Hypotonia 337, 371
Hypoxia 56, 577
Hysteria 125
I
Ibuprofen 28
Ictal
akinesia, unilateral 242
aphasia 242
eye blinking, unilateral 241
spitting 241
vomiting 241
Idarucizumab 134
Idiopathic facial pain, persistent 6365, 67
Ifosfamide 468
Iloperidone 384
Imipramine 11
Immunoglobulin 373, 460, 615, 728
intravenous 326, 403, 405, 452, 611, 616
Immunohistochemistry 647, 704, 713
Inappropriate antidiuretic hormone secretion, syndrome of 232
Inclusion body myositis 654, 707
Indolones 384
Indomethacin 866
Infant motor performance, test of 699
Infantile
epilepsy, benign 173
myopathy 669
seizures, benign 201, 202
Infarction 5
hemorrhagic 154
venous 482
Inflammation 27
perivascular 729f
Inflammatory bowel disease 612
Inflammatory myopathies
idiopathic 654, 704
juvenile 656
Influenza 448
Infracalcarine fissure 237
Insomnia 568
Insulin 535
Insulin-like growth factor 535, 825
Interleukin 190, 525
Internuclear ophthalmoplegia
bilateral 486
unilateral 486
Interpositus nuclei 369
Intracavernous carotid artery, pseudoaneurysm of 41
Intracranial
hypertension
idiopathic 50, 53, 54, 866
spontaneous 4, 45, 54, 143
pressure 4, 7, 72, 135
management of raised 132
Intraepidermal nerve fiber 619, 621
density 622
Intranasal drug delivery 827
Intra-ocular pressure 21
Intrathecal
baclofen pump 804
delivery 804
device 829f
drug delivery 829
injection 50
Intrinsic cardiac ganglia 870
Intrinsic severity hypothesis 188, 188f
Iodine 11
Ipsilateral
ictal piloerection 238
signs 369
tongue biting 242
Iron mapping 847
Irritable bowel syndrome 837
Isavuconazole 105
Ischemic
leukoencephalopathy, subcortical 482, 483
ocular motor nerve palsy 16
stroke 4, 49, 115, 124, 127, 137, 143, 148, 232
Isoniazid 85, 606, 752, 754, 758, 779, 864, 868
Itraconazole 105
J
Japanese encephalitis 96, 97, 97f, 98f, 101, 448
diagnosis of 97
virus 96
Jeavons syndrome 206
Jerky hyperkinetic movements 342
Jitter values, abnormal 834f
Juvenile absence epilepsy 173, 178, 206, 207
K
Kayser-Fleischer
corneal pigment 321
ring 322, 322f
Kearns Sayre syndrome 575, 638, 669, 716
Kennedy's syndrome 589
Kernig's signs 72
Kerosene 11
Ketoprofen 28
Kinetic
dysfunction 370
tremors 358
Klebsiella 71
Kleine-Levin syndrome 179, 185
Kny's myoclonus 329
Kolkata verbal memory test 548
Korsakoff's syndrome 469, 570
Krabbé disease 725
Kuf's disease 573
Kugelberg Welander disease 697
Kyphoscoliosis 639
L
Labetalol 132, 781
Lacosamide 227, 262, 752
Lacrimal gland retention cyst 42
Lactic
acidemias 573
acidosis 50, 147, 185, 333, 478, 575, 638, 669, 716
stroke-like episode syndrome 190
Lactobacilli 838, 839
Lafora body disease 207
Lambert-Eaton myasthenic syndrome 627, 630, 632
Lamotrigine 65, 211, 216, 221, 228, 262
Lance-Adams myoclonus 330
Landau-Kleffner syndrome 173
Language 492, 497, 524, 548
disturbances 337
dysfunction 433
Large-artery atherosclerosis 116,121
Lathyrism 766, 768
Lathyrus sativus 766768
Lead 11, 475, 482, 577, 605, 725, 752, 753, 758, 774, 776778
Leber's hereditary optic neuropathy 575, 716
Legionella 448
Leigh syndrome 669
Lennox-Gastaut syndrome 173, 177, 196, 206, 211, 226
Lenticular degeneration, progressive 319
Leprosy 588f, 590, 725, 731
late-onset neuropathy 605
lepromatous 732f
multibacillary 605
paucibacillary 605
neuritis, reactional 605
neuropathy 604t
classical 604
treatment of 605t
Leptin 828
Leptospira 448
Lesch-Nyhan syndrome 573, 580
Lethal catatonia 425
Lethargy 524
Leukocyte
activation, peripheral 190f
Leukodystrophy 516, 573, 577, 582, 725
Leukoencephalopathy 50, 52, 147, 471, 473f, 476, 480, 546
drug-induced 471
environmental toxin-induced 473
megalencephalic 579
Levetiracetam 211, 217, 227, 263, 405, 752, 865
Levodopa 290, 300, 865, 868
carbidopa gel 300
resistant akinetic-rigid syndrome 308
Levofloxacin 865
Levosulpiride 384
Lewis summer syndrome 589, 610
Lewy body 287, 308, 311, 312, 333, 515, 516, 519, 520, 558561, 564
dementia, diffuse 288
disease 354
diffuse 307, 342
Lidocaine 867
transdermal patches of 828
Limb 370
apraxia, left 547
dystonias 365
Limb girdle muscular dystrophy 710
Limbic encephalitis, autoimmune 569t
Linagliptine 317
Linezolid 76, 606
Lipid 440
metabolism, disorders of 661t, 666, 667
rich necrotic core 844
storage myopathy 668f
Lipoprotein
disorders 594
low density 825
Liposomal amphotericin B 105
Lisinopril 21
Listeria monocytogenes 71, 75, 233
Lithium 11, 374, 379, 570, 754, 758, 776, 781, 864, 865, 867
carbonate 11
Liver
diseases 226
enzymes 65
failure
acute 226
chronic 226
function test 65, 591, 755
transplant, orthotopic 226
Logopenic progressive aphasia 554
Losartan 303
Lower limb
ataxia of 369
paresis, bilateral 678
Loxapine 384
L-tryptophan 776, 781
Lugol's iodine 581f
Lumbar puncture 53, 72, 451
Lung 568
cancer 568
carcinoma of 590
malignancy 42
Lupus chorea 338
Lyme's disease 335, 482, 483, 516, 603
Lymphadenopathy 65, 99
Lymphoid cell infiltrate 729f
Lysergic acid diethylamide 752
Lysosomal storage disorders 573, 577, 579t
M
Macroadenoma 232
Maculoanesthetic patch 588f
Magnesium 677
Magnetic resonance
angiography 118
imaging 37, 52, 60, 64, 81, 83t, 90, 97, 118, 200, 215, 228, 253, 257, 288, 308, 373, 444, 450, 451, 454, 458, 479t, 483, 541, 552, 561, 565, 574, 658, 659, 674, 744, 756t, 768
brachial plexus 615
brain 458
lumbosacral plexus 615
spinal roots 615
spine 690
spectroscopy 541, 848
Magnetoencephalography 189, 252, 257
Malaria 577, 792
Malondialdehyde, serum 321
Manganese 752, 756
Mania 568, 864
Mannitol hexanitrate 11
Maprotiline 29
Marchiafava-Bignami disease 441, 463, 473, 480
Marijuana 752
Markesbery-Griggs myopathy 640, 651
Masaoka staging system 630
Matrix metalloproteinase 142
Maxillary cyst 41
McArdle's disease 662, 664, 723f
McLeod blood group 338
McLeod syndrome 338, 640
Mean corpuscular volume 622
Measles 335, 448
Medium-chain acyl-coenzyme dehydrogenase deficiency 667
Medroxyprogesterone 358
Memantine 29
Memorial delirium assessment scale 525
Memory 493, 495
disorders 820, 864
epigenetic 818
episodic 496
Meniere's disease 179
Meningioma 41
Meningitis 74, 104, 849
acute 232
bacterial 56, 75t
carcinomatous 50, 516
chronic 232
lymphocytic 104
cryptococcal 106t
fungal 104
granulomatous 104
monocytic predominance 104
purulent 75f
pyogenic 71, 74
score, bacterial 74
spinal 78
tuberculous 78, 79, 83f, 85t, 849
Meningoencephalitis 56, 104, 478
Menstruation 10, 19
Mental
disorders 407
manual of 429
secondary 864
function 491, 750, 864
retardation 173
status 120
tension 10
Meperidine 867
Mercury 11, 577, 752, 758, 774, 776
Meropenem 75, 76
Merosin
deficient congenital muscular dystrophy 647
immunostaining, loss of 714f
Mesial temporal lobe epilepsy 189, 206, 208
Messenger ribonucleic acid 356, 594
Metabolic acidosis 65
Metabolic disorders 179, 232, 334, 524, 573, 577, 725
Metaiodobenzylguanidine 623
Metformin 766, 768
Methadone 380
Methanol 475, 752, 755, 756, 758
Methaqualone 868
Methicillin resistant 76
Methimazole 868
Methotrexate 474, 482, 577, 752, 756, 867
Methyl alcohol 11
Methyl bromide 11
Methyl chloride 11
Methyl chloroform 774
Methyl iodine 11
Methyl N-butyl ketone 774
Methylation 810
Methylenetetrahydrofolate deficiency 482
Methylphenidate 865
Methysergide 868
Metoclopramide 383, 384, 865
Metronidazole 474, 590, 606, 752, 754, 779, 864, 868
Mianserin 29
Micafungin 105
Microcystic macular edema 458
Micro-ribonucleic acid 813
Microvascular decompression, role of 39
Midazolam 227
Midbrain atrophy visible 309f
Middle cerebellar peduncle sign 356f
Middle cerebral artery 121, 508
infarctions 41
Migraine 5, 6, 10, 14, 15, 17, 21t, 35, 35t, 179, 183, 214, 477f, 482, 789, 828
abdominal 15
basilar 179
chronic 7, 17, 19
chronification of 6t
classification of 17
complications of 17
cyclical 7
disability assessment scale 12
generator 19
headaches 7
hemiplegic 17, 392
prevention of 21
Milkmaid's grip 336, 343
Miller fisher syndrome 589, 478, 608t, 609
Mineral accumulation, disorders of 573
Mineral metabolism, disorders of 573
Minocycline 11, 167, 781
Miosis 9, 33, 36, 38, 40
Mirror therapy, role of 166
Mirtazapine 29
Mitochondrial
disease 483, 637, 641
dysfunction 539
myopathy 333, 670f, 717f
Mitochondrial recessive ataxia syndrome 376, 669
Mixed connective tissue disorder 231
Miyoshi myopathy 651
Molindone 384
Monoamine oxidase inhibitors 291, 379
Monoclonal
antibody, development of 825
gammopathy of undetermined significance 616
plasma cell disorder 615
Monosodium glutamate 10, 11, 50
Mood
disorders 837
disturbance 21
stabilizers 867
Morning glory sign 309f
Morphine 752
Morvan's fibrillary chorea 329
Moth-eaten fibers 713, 714
Motor
association cortex 505
complications 297
management of 299t
treatment of 299
control 874
evoked potential monitoring 834
movement 183
generation of 798f
nerve conduction study 735
neuron
disease 482, 672, 675, 676f, 677, 681
lower 677, 681, 683
survival 697
neuropathy 610
hereditary 697, 698
multifocal 615
symptoms 284
system 121, 337, 595
tics 428
weakness 152
Movement disorder 179, 269, 327, 341, 341t, 344, 347, 365, 415, 422, 843, 849, 862
chronic 424
drug-induced 867
epidemiology of 276
psychogenic 407
types of 344
Moxifloxacin 76
Moyamoya disease 482
Mucorales genera 105
Mucormycosis 111f, 104
Multicellular dysfunction 816
Multifocal leukoencephalopathy, progressive 232, 442, 460, 463, 465, 478480, 482, 516, 566, 577
Multi-minicore disease 717, 719f
Multiple sclerosis 483, 516, 878
hemisphertic 486
primary progressive 445
Multisystem disorder 594
Mumps 335, 448
Muscle
action potential 831
biopsy 658, 662f, 664, 702, 703f, 704t, 717f, 721f, 723f
cramps 65
damage 781
disease 638641, 704t
classification of 704, 704t
disorder 821, 862
dysfunction 99
eye-brain disease 649
fibers 833f
hypertrophy of 639
specific antibodies 657
spindle 798f
discharges 366
stiffness 799f
toxicity 781
Muscular atrophy, progressive 672, 683
Muscular dystrophy 710f, 712f, 713f, 743
congenital 638, 641, 642, 647, 648t, 708, 713, 714
myotonic 715f
oculopharyngeal 637, 638, 641, 650, 713, 816
X-linked 642, 708
Musculoskeletal system 595, 849f
Mutism 524
Myalgia 781
Myasthenia gravis 627, 628, 628f, 629t, 631
drug induced 629
score, quantitative 629t
Myasthenic syndromes 678
congenital 627, 629, 632
Mycobacterium tuberculosis 79, 81, 84
Mycology 103, 106
Mycophenolate mofetil 459, 460
Mycoplasma pneumoniae 335, 448
Mycotic aneurysms 141
Mydriasis 65
Myelin 439, 440t, 726
basic protein 440, 727, 727f
constituents of 439
disorders 816
oligodendrocyte glycoprotein 439, 440, 454, 455, 457
protein, peripheral 440, 597, 745
sheath 439
Myelination 440, 441, 839
Myelinolysis, extrapontine 334, 466, 468f, 479
Myelitis
acute 455
complete transverse 486
Myelography 60
Myelo-optic neuropathy, subacute 768, 769
Myelopathy 486, 486t, 520, 751, 772
autoimmune 478
electrocution-induced 772
hepatic 766, 768, 771
metformin-induced 772
paraneoplastic 478, 616
radiation-induced 771
Myoadenylate deaminase deficiency 668
Myocardial infarction 132
Myocarditis 74
Myoclonic
astatic epilepsy 206, 211
atonic 173
disorders, treatment of 332fc
encephalopathy, early 173, 202
epilepsy
benign 201, 206
juvenile 173, 178, 206, 206f, 211, 220, 265, 332
progressive 173, 206, 207, 333, 478, 581
severe 203
jerks 582f
Myoclonus 329, 342, 374, 401, 409, 520, 669
classification of 330
cortical 329
dystonia 348
syndrome 331, 344
electrophysiological evaluation of 331
epileptic 330
etiological classification of 330t
fibrillaris multiplex 329
functional 410
nonepileptic 330
peripheral 331
posthypoxic 329, 333
psychogenic 331
spinal 331
subcortical 331
treatment of 332
types of 330t
Myoepithelial cells 581f
Myofiber 719f
necrosis 728
Myofibrillar myopathy 642, 646, 652
Myogenic disorder 744
Myoneural gastrointestinal encephalopathy 638
Myopathy 375, 667, 669, 753, 869
alcohol-induced 785
centronuclear 717, 719f
congenital 638, 641, 704, 716, 717, 717t
drug induced 704
idiopathic inflammatory 707t
inflammatory 636, 654, 704, 706, 708t
drug induced 784
metabolic 636, 637t, 661, 671, 704, 717
mitochondrial 668, 669, 669t, 714
necrotizing 782
spectrum of drug-induced 782
X-linked 666
Myophosphorylase deficiency 662
Myositis 657t
syndromes, overlap 656
specific antibodies 657
Myotonia 639
chondrodystrophic 639
prominent 639
Myotonic dystrophy 652
Myxedema 590
N
Nalidixic acid 11, 868
Naloxone 828
Naphthalene 11
Naproxen 28
Naratriptan 20
Narcolepsy 179, 214
symptomatic 455
Nasal congestion 9, 33, 36, 38, 40
National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Disease, and Stroke 162
Nausea 65, 99
Neck 59
disorder of 56, 59
injury 41
pain 50
Necrotic fibers 713
Necrotizing autoimmune
myopathy 654, 656, 658, 659
myositis 655
Neisseria meningitis 75
Nemaline 641
rod myopathy 717, 720f
Neonatal
myasthenia gravis, transient 629
sleep myoclonus, benign 185
Neoplasm 232
intracranial 50
Nerve 862
biopsy 592, 615, 725, 725t, 727, 727t, 730f, 731f, 733f, 744
complications of 726
interpretation 725
processing 726
site of 725
conduction 440f
studies 379, 590, 683, 734
fiber loss, multifocal 728
growth factor 619
normal histology of 727
palpation 595
peripheral 587
stimulation
repetitive 737f
test, repetitive 736
Nerve conduction velocity test 629
Nervous system
examination 750
pathology 347
peripheral 450, 587
role of 841
Nervus intermedius
neuralgia 16, 6366
classical 63
neuropathy 63
N-ethylmaleimide sensitive factor 361
Neuralgia 63, 64, 65t
glossopharyngeal 6365, 67
occipital 16
Neuralgiform headache attacks 8, 31, 38f
Neuraxis 329t
Neuroacanthocytosis 338
syndromes 334
Neurocognitive disorder 567
Neurocutaneous syndromes 203
Neurocysticercosis 848, 849f
Neurodeficits 750
Neurodegenerative disease 552, 763, 809
Neuroendocrine 568
abnormalities 523
Neuroendoscope 135
Neurogenic
atrophy 720
bladder 486
muscle weakness 375
Neuroinflammation 523
Neurolathyrism 767, 767f, 768t
Neuroleptic 435
malignant syndrome 74, 232, 423, 862, 865
sensitivity 560
Neurologic
disorders, episodic 392
syndromes, secondary 232
Neurological disorders 392t, 797, 819
drug-induced 862
Neuroma 726
Neuromuscular
blockade 869
disorders 704, 742, 743, 833f
genetic evaluation of 746
junction 627, 628f, 749
disorder 741, 753
physiology, normal 627
transmission disorder 678
Neuromyelitis optica 441, 445, 454, 464, 846
spectrum disorders 454, 455, 457, 459, 460t, 478
pediatric 457
Neuronal apoptosis inhibitory protein 696
Neuronal ceroid lipofuscinosis 573, 581
juvenile 207
Neuropathic tremor syndrome 357
Neuropathy 520, 669, 753
acquired 602
alcoholic 605, 779
cancer-associated 621
diphtheritic 604
drug-induced 604
hereditary 593, 598, 599, 612, 744t
hypertrophic 730
immune-mediated 607
infection related 603
localized 868
painful 589f
peripheral 587, 862
topography of 589
types of 753
Neuropsychiatric
disorders 839
drug-induced 864
inventory 494, 548
symptoms 285, 291, 540
Neurorehabilitation 787, 789791, 793, 794, 858, 873
complications of 790, 790f
early 793
goals of 790
neuroenhancement methods of 873
Neuroretinitis 486
Neurosarcoidosis 50, 482, 516
Neurosurgery 860
role of 83
Neurosyphilis 482, 516, 567
Neurotoxicity 863
radiation-induced 471
Neurotoxins 755t
Neutral lipid storage disease 667
N-hexane 774776, 778
Niacin 516
Nicardipine 132
Nicotine 11
Niemann-Pick disease 207, 573, 582
Nifedipine 11, 303
Nitrates 758
Nitrazepam 303
Nitric oxide 50, 142, 166
Nitrofurantoin 776, 868
Nitroglycerin 10, 131
Nitrous oxide 753, 766, 768, 776
myelopathy 770
N-methyl-D-aspartate 205, 291, 300, 542
receptor 530, 568, 569
Nodes of Ranvier 439
Nonaka's myopathy 640
Nonepileptic seizures, psychogenic 183, 209
Nonfamilial neonatal seizures, benign 201
Nonfluent aphasia, progressive 495, 553
Nonheadache medication 11, 51
use of 51
Noninfectious inflammatory intracranial disease 50
Noninvasive novel drug delivery systems 825
Nonketotic hyperosmolar coma 229
Nonmotor symptoms
management of 302t
sweeping survey of 314
Nonprion central nervous system infections 564
Nonprogressive disorders 173
Nonsteroidal anti-inflammatory drug 11, 28, 51, 57, 278
Nonsystemic vasculitic neuropathy 616
Nonvascular intracranial disorder 14, 50
Nortriptyline 29
Novel drug delivery system, classification of 824fc
Nuclear
antibody, antineuronal 377
deoxyribonucleic acid 668
Nucleoside reverse transcriptase inhibitor 781
Nummular headache 44, 46
Nutrition 327
Nutritional
deficiency 607
neuropathies 607, 607t
Nystagmus 241, 374
O
Obsessive compulsive disorder 415, 429
Obstructive sleep apnea 184, 656, 698, 214b
Occipital nerve
block 30
stimulation 36
Ocular inflammatory disorder 56
Oculobulbar paresis 637
Oculomotor
apraxias 372, 376
system 120, 374
Odontalgia, atypical 67
Ohtahara syndrome 173, 202
Olanzapine 384, 865
Olfactory dysfunction 284, 289
Oligoclonal bands 451, 484
Oligohidrosis 65
Omphalocele 222
Onabotulinum toxin A 351
Onconeuronal antigen 568
One-half syndrome 486
Ophthalmoparesis 638
Ophthalmoplegia 669
Opioid 11, 380, 758, 866
analgesics 865
overuse headache 51
Opportunistic infections 232, 478
Opsoclonus-myoclonus syndrome 331
Optic
nerve 458, 486t
neuritis 16, 449, 454, 455, 486, 862, 869
acute 455
recurrent 457
simultaneous bilateral 486
neuropathy, progressive 486
Optical coherence tomography 458
Oral contraceptive 221, 863
Oral glucose tolerance test 615
Orbitosphenoidal aspergillosis 41
Orchitis 74
Organic acid disorders 573, 579t
Organochlorine 774
Organophosphate 590, 605, 752, 753, 758, 774, 776, 778
Ornithine transcarbamylase deficiency 573, 579
Oromandibular dystonia 97f, 364
Orthographic output lexicon 510
Osmotic demyelination syndrome 463, 466, 478
Osteomyelitis 71
Otitis 71
Ovarian teratoma 568
Ovary, carcinoma of 590
Oxcarbazepine 65, 211, 216, 227, 263
Oxidative stress 384, 523, 534
Oxycodone 380, 866
P
Paget's disease 67
Pain 302, 303, 366, 486, 526, 867
abdominal 21
character of 6
chronic 138
neuropathic 619, 625
persistent 726
retro-orbital 99
Palatal myoclonus 331
Paliperidone 384
Pallidotomy 301
Panayiotopoulos syndrome 173
Pancoast tumor 41
Pancreatitis 65
Panic attacks 179
Panophthalmitis 74
Papilledema 152
Paracetamol 28, 51, 137, 866
Paracocidioido mycosis 104
Paraesthesias 21
Parahippocampal gyrus 531f
Paramyotonia congenita 639
Paranasal sinuses 56
Paraneoplastic syndrome 620
degeneration-associated antibodies 377t
Paranoia 864
Paraparesis 79
Paraproteinemia 590, 621
Parasagittal cortex 237
Parasitic infection 56
Parasomnia 179, 184
Parathyroid disorders 231
Paratrigeminal oculosympathetic syndrome 16
Paresthesia 608, 726, 868
Parieto-occipital junction 237
Parkinson's disease 276, 276t, 277t, 278, 278t, 279, 281, 283, 284, 284f, 285292, 296, 296t, 297, 299t, 303, 311, 314316, 342, 344, 354, 378, 415, 422, 482, 516, 530, 558, 559, 789, 794, 812, 819, 839, 840fc, 850, 852, 858, 868
advanced 296, 299, 302t, 304
diagnosis of 287
early 283, 287
idiopathic 307, 342, 558, 762, 819
prevalence of 277t
rating scale 415
symptoms of 314
treatment 290fc
Parkinson's plus syndromes 286
Parkinsonism 839
acute 422
causes of 850
drug induced 287, 288
functional 410
secondary 307
tremor of 354
Parotid epidermoid metastases 41
Paroxysmal
disorders 334
dyskinesia 179, 389, 391t
classification of 389
secondary 390
exercise-induced dyskinesia 390, 391t, 392
hemicrania 6, 31, 34, 36
chronic 31, 36
episodic 8, 31, 36
secondary 41
kinesigenic dyskinesia 389, 390, 390f, 391t, 392, 393
nonkinesigenic dyskinesia 389, 390, 391t, 392
positional vertigo, benign 179
tonic upward gaze, benign 185
torticollis 15
benign 17
vertigo 15
benign 17
Partial epilepsy, benign 211
Patent foramen ovale 117, 147
Penicillamine 781
Penicillin 75, 76, 868
minimum inhibitory concentration 76
Penn spasm frequency scale 799, 800t
Pentaerythrityl tetranitrate 11
Perchloroethylene 774
Percutaneous endoscopic gastrostomy 682f
Pergolide 380
Perhexiline 775, 868
Pericarditis 74
Perimesencephalic hemorrhage, idiopathic 141
Perinatal cerebral ischemia 203
Perineuritis 725
Periodic
acid Schiff 529, 662, 726
limb movement 379
paralysis 179
hypokalemic 720
Peripapillary retinal nerve fiber layer 458
Peripheral neuropathy 868t
drug-induced 868
Peroxisomal disorders 573, 577, 594
Pertussis 448
Pethidine 866
Petrous ridge meningioma 41
Phagocytosis 713
Phantom tooth pain 67
Phenacetin 866
Phenelzine 868
Phenobarbital 211, 263, 758
Phenobarbitone 227, 752
Phenothiazines 866
Phenytoin 211, 216, 263, 374, 468, 570, 590, 752, 754, 776, 864, 868
sodium 227
Pheochromocytoma 179
Phonic tics 428
Phonological
input lexicon 510
output lexicon 510
Phonophobia 26
Phosphodiesterase 165
inhibitor-induced headache 11, 50
Phosphofructokinase deficiency 664
Photon emission computed tomography, single 257, 541, 552, 553
Photophobia 26
Picture naming test 548
Pimozide 384, 435
Pituitary disorders 232
Pizotifen 21
Plantar reflex 183
Plaque inflammation 844
Plasma
cell disorder, monoclonal 610
exchange 405, 452, 611, 631
Plasmapheresis 631
Platyspondyly 639
Pleurisy 74
Pluripotent stem cell 817, 817f
human induced 818, 818t
Podophyllum 868
Polio 448
Poliomyelitis 692
Polyarteritis nodosa 148, 516, 728f
Polyenes 105
Poly-hill sign 650f
Polymerase chain reaction 90
Polymeric micelles 827
Polymorphonuclear leukocytes 442
Polymyositis 630, 654, 655, 658, 659t, 704, 705f, 707
treatment of 659
Polyneuropathy 615, 620
Pompe disease 664, 665, 722f
Pontomedullary compression 42
Porphyria 230, 483, 573, 580, 594, 621
Posaconazole 105
Positron emission tomography 257, 288, 308, 552, 553, 622
fluorodeoxyglucose 520, 541, 847
imaging 561
scans 532
Postanoxic myoclonus 330
Posterior reversible encephalopathy syndrome 4, 5, 228, 234, 234f, 463, 472, 475, 478, 480
Postherpetic trigeminal neuropathy 63
Postictal paresis 242
Postpolio progressive muscular atrophy 692, 693f
Postpolio syndrome 681, 692, 694, 795, 857
Post-traumatic trigeminal neuropathy, painful 63
Postural orthostatic tachycardia syndrome 54, 620, 623
Pott's paraplegia 78
Pott's spine 78
Pramipexole 380
Praxbind 134
Pregabalin 65, 380
Presynaptic congenital myasthenic syndromes 633
Primidone 211, 264
Procainamide 612, 775, 781
Procalcitonin 525
Procarbazine 868
Prochlorperazine 384
Prodrug delivery systems 825
Progressive external ophthalmoplegia 669
Progressive myoclonic epilepsies, causes of 207
Progressive supranuclear palsy, diagnosis of 309
Prolactinoma 42
Proline rich transmembrane protein 2 gene 392
Propionibacterium acnes 75, 76
Propofol 781
Propoxyphene 866
Propranolol 20, 21, 866, 868
Propylene glycol 758
Propylthiouracil 868
Prosopagnosia 547
Prostration 99
Protein bound
agents 134
fraction 229
Protein-gene product 727
Prothrombin complex concentrates 133
Protriptyline 29
Proximal spinal muscular atrophy, classical 696
Pseudodementia 571
Pseudohypoparathyroidism 334
Pseudomonas aeruginosa 75, 76
Pseudosclerosis 272
Pseudosyncope 183
Psychiatric disorder 14, 61, 179, 864
Psychosis 298, 302, 315, 326, 422, 864
Ptosis 9, 33, 36, 38, 40
Pulmonary function tests 699
Pulse pressure 99
Purine nucleotide metabolism, disorders of 668
Purkinje cell antibody 377
Putamen, atrophy of 312
Pyramidal signs, bilateral 449
Pyrazinamide 752
Pyridostigmine 633
Pyridoxine 606, 754, 868
dependency 204
Pyrimidine 105
Pyrimidinone 384
Pyruvate carboxylase deficiency 334
Q
Quantitative sensory testing 621, 623
Quantitative sudomotor axon reflex test 623, 624
Quetiapine 312, 384
Quinolinone 384
Quinolones 752, 867
R
Rabies 425, 448, 564, 604
Radiation 766, 768
injury 479
acute 479
leukoencephalopathy 463
toxicity 478
Raeder's syndrome 16
Rapamycin 535
Rapid eye movement behavior sleep disorders 214b
Rapidly progressive dementia, epidemiology of 564
Reflex epilepsies 173b, 207
Refractory myasthenia gravis 632
Refsum's disease 376, 573, 594
Regional muscular dystrophies 649
Remoxipride 384
Renal failure 228, 229
chronic 228, 590
treatment of 229
Renal function tests 149t, 214, 591
Respiratory
chain disorder 573, 576, 582
distress 698
muscle involvement, early 641
Responsive neural stimulation 257
Rest tremor 354
drug-induced 358
Restless legs syndrome 214, 378380, 380t
etiology of 378
exacerbating 379
Retinal
degeneration 374
diseases 821
migraine 17
Retrobulbar neuritis 869
Retroclival hematoma 4
Retrocollis 386f
Retropharyngeal tendonitis 56
Rey auditory verbal learning test 493
Reye's syndrome 226
Rhabdomyolysis 65
Rheumatoid disease 612
Rhinocerebral forms 104
Rhinorrhea 9, 33, 36, 38, 40
Riboflavin 21
Richardson's syndrome 310
Rifampicin 85, 752
test 81
Risperidone 85, 384, 865
Rituximab 405, 460
Rivastigmine 312, 828
Reversible cerebral vasoconstriction syndromes 4, 5, 53, 57, 143, 147
Rizatriptan 20
Robotic
exoskeleton 858f
gait orthosis 859f
motor training devices, types of 857
role of 861
technology 166
Romberg's sign 369
Ropinirole 380
Rotigotine 828
patch 380
Rubella 448
S
Salaam attacks 202
Salicylate 758, 866
poisoning 74
Sarcoglycanopathies 639, 647, 710
Sarcoidosis 231, 612, 620, 725, 731
Saxagliptine 317
Scapulohumeral weakness 637
Scapuloperoneal
dystrophy 642
muscular dystrophy 708
syndromes 637
weakness, types of 637
Schirmer's test 623
Schizophrenia, catatonic 74
Schmidt-Lanterman clefts 439
Schumacher criteria 444
Schwann cell 439, 731f
Schwartz Jampel syndrome 639
Scleroderma 231
Sclerosing panencephalitis, subacute 207, 208f, 333, 335, 463, 466, 478, 479, 484, 516, 564, 566, 577
Sclerosis
multiple 41, 64, 372, 441, 444, 448, 452t, 457, 464, 478, 480, 482, 483, 485, 520, 789, 793, 794, 797, 846, 846f, 878
pathogenesis of multiple 841
plaque, multiple 63
primary lateral 672, 683
systemic 630
Seizure 79, 137, 181, 203, 214, 226, 228, 229, 231233, 326, 375, 449, 486, 758
dialeptic 241
disorders 862
drug-induced 867
epileptic 50, 183, 205
etiology of 232t
focal 179
frequency 248
nonepileptic 206
outcome 221
semiology 236, 248
classification 172
Sella turcica, gangliocytoma of 41
Semantic
dementia 495, 516, 551, 554
fluency 548
memory 496
system 510
Senile chorea 335
Sensory
ataxia 368, 371, 669
progressive 486
ataxic neuropathy 638
auras 236
deficits 610
examination 751
loss 726
motor
neuropathy 868
myelopathy, partial 486
neuropathies 594, 727f, 868
symptoms 285
trick 343
Sensory motor syndrome 121
Sepsis 74
Serotonergic syndrome 423
Selective serotonin reuptake inhibitors 29, 167, 379, 556, 865
Serotonin syndrome 74, 862, 865
Severity assessment scale 339
Shill-Gerber criteria 408t
Shock 99
Shoulder girdle weakness 635
Small-artery occlusion 116, 121
Sialidosis 207, 579
Sialorrhea 365
Sickle cell disease 141, 147
Sildenafil 11, 165
Single cell lines, abnormalities of 816
Sinusitis 71
complicated 143
Sjögren's syndrome 148, 231, 482, 569, 570, 588590, 612, 620
Skeletal
abnormalities 639
survey 615
Skin
biopsy 622, 715f
lesion paucibacillary leprosy, single 605
Skull base aspergillosis 109f
Skull base syndromes 104
Sleep
apnea 179
headache 56
behavioral disorder 179, 559
disorders 184, 214, 560, 562, 862
disturbance 21, 299, 302, 303
fragmentation 299
maintenance insomnia 299
myoclonus 179
Slow-channel syndrome 633
Small cell lung cancer 377t, 568, 569
Small fiber neuropathy
causes of 590
painful 605
Small vessel disease 147
Smallpox 448
Snake venom 752, 758, 781
SNARE protein complex formation 361f
Sodium
nitroprusside 11
valproate 21, 227
Solid organ transplantation 612
Somatization disorder 56
Somatosensory cortex, primary 237
Spasm
epileptic 174
unilateral 240
Spasmodic torticollis 185
Spasmus nutans 185, 357
Spastic paraplegia 375
progressive 486
Spasticity 365, 797, 801
evaluation of 799
management of 801fc
numeric rating scale 799, 801t
pathophysiology of 797
progressive 482
Speech 242, 504
aphasia, impairment of 449
apraxia of 554
impairment of 449
language
pathologists 504
therapy 511, 512, 512t
slow, impairment of 449
slurred, impairment of 449
Sphenoid
lesser wing of 41
mesenchymal tumor of 42
Sphenopalatine ganglion 35
Sphingomyelin 440
Spider leg appearance 81
Spinal cord 458, 797, 870
affection, partial 486
degeneration of 463, 469
disorders 858
injury 797, 821
Spinal muscular atrophy 696698, 699t, 700, 700t, 723, 724f
management of 699t
Spinal muscular atrophy spectrum disorders 697t
types of 697
Spinocerebellar ataxia 376
Split hand syndrome 681
reverse 688f
Sporadic inclusion body myositis 655, 656, 658, 705
Squint, persistent 56
Staphylococcus aureus 71, 75, 76
Staphylococcus epidermidis 75, 76
Startle disease 185
Status dystonicus 424
Status migrainosus 17
Stavudine 868
Stellate ganglion block 67
Stem cell 165, 828
mesenchymal 821
research 166, 815, 819
therapy 699, 815, 816t, 817, 818
Stereo-encephalography 253
Sternocleidomastoid 120
Steroid 611, 644
anabolic 11
myopathy 785
Stevens-Johnson syndrome 66, 217
Stiff person syndrome 400, 400t, 401, 404fc, 425
classification 400
diagnosis 403
epidemiology 400
pathophysiology 401
treatment 403
Stigma, types of 246f
Strenuous unaccustomed exercise 19
Streptococcus agalactiae 75, 76
Streptococcus pneumoniae 71, 75, 76
Streptomycin 85, 868
Stress 10
emotional 10
Stretch reflex
arc 798f
spinal influence of 798f
Striatal gamma-aminobutyric acid neurons dysfunction 384
Stroke 74, 80, 116, 118, 119, 125, 125t, 146, 149, 166, 792, 793, 797, 821, 843fc, 857, 863
acute 124
cardioembolic 115, 116
causes of 147t
classifications 117
control of 162
cryptogenic 116, 149
embolic 117
genetics 148
hemorrhagic 131
ischemic 116, 127, 129
like episodes 147, 185, 575, 638, 716
prevention 162
drugs of 161
strategies 159
primary prevention of 159
primordial prevention of 159
rehabilitation 792, 793
riskometer 161
secondary prevention of 161
subtypes 115, 121, 147
syndromes 104
classic 121
treatment classification, acute 115
venous 115
vertebrobasilar 478
Strychnine toxicity 425
Sturge-Weber syndrome 50
Stylohyoid ligament, inflammation of 56
Subarachnoid Hemorrhage Scale 143t
Subcortical myoclonus, treatment of 332fc
Subcortical nuclei, dysfunction of 298
Substance abuse 478, 752, 863
Substantia nigra
hyperintensity 98f
pars compacta 396
Subthalamic nucleus 300, 301, 396, 417f, 418f
Subthalamic nucleus, connections of 396f
Succinylcholine 785
Sudomotor function 624
Sulfonamide 868
Sulfoxone 868
Sulpiride 384
Sulthiame 211, 868
Sumatriptan 20, 866
Superior sagittal sinus 153, 230f
Supracalcarine fissure 237
Supramarginal gyrus 505
Supranuclear palsy, progressive 286, 288, 307, 308, 310, 313, 342, 516, 519, 555, 850
Supraorbital transcutaneous stimulation 21
Sydenham's chorea 269, 335, 336
epidemiology 336
management of 336
pathophysiology 336
Synaptic plasticity 385
Syncope 179, 182
cardiogenic 871
Syphilis 564, 577
Systemic lupus erythematosus 147, 229, 230, 230f, 335, 338, 482, 516, 569, 590, 612, 620
T
Tachycardia 65
compensatory 624f
Tacrolimus 606, 612, 775, 781
Tadalafil 165
Takayasu's disease 147
Tangier's disease 588, 590, 620
Tardieu scale 799, 800t
modified 799, 800t
Tardive
akathisia 386
dyskinesia 383, 385, 385f, 387, 862
dystonia 350, 385, 386f
myoclonus 386
parkinsonism 386
stereotypy 385
syndromes 383, 384, 387, 862, 867
tics 386
tremor 386
Target hypothesis 188, 188f
Tarui's disease 664
Tassinari syndrome 206
Tau hypothesis 539
Taxanes 868
Taylor complex figure, modified 548
Tay-Sach disease 376
Telangiectasia 334
Teletherapy 513
Telethoninopathy 640
Temporal lobe 237
epilepsy 182, 209f, 210f, 237, 248
Temporomandibular disorder 56, 61
Temporomandibular joint 61
Temporo-parietal cortex, left 844f
Tendoachilles contracture 638
Teratogenicity 65
Tetanus 425, 448, 752
Tetrabenazine 435, 865
Tetracycline 11
Tetralogy of Fallot 222
Thalamic tremor 357
Thalamo-ganglionic hyperintensity 155f
Thalamus 395
parafascicular nucleus of 396
Thalidomide 752, 754, 868
Thallium 605, 752, 753, 755, 758, 774, 776, 777
Theophylline 758
Thermoregulatory skin test 624
Thiamine 516, 607
Thiamphenicol 868
Thienobenzodiazepine 384
Thiopurine methyltransferase 460
Thioridazine 384, 865
Thiothixene 384
Thioxanthenes 384
Third ventricle colloid cyst 4
Thorium 577
Thrombocythemia, essential 41
Thrombocytopenia 99
Thrombocytopenic purpura, idiopathic 630
Thromboembolic disease, drug-induced 863
Thrombolysis 127, 149
Thromboprophylaxis 137
Thrombotic thrombocytopenic purpura 74
Thymectomy 631
Thymoma 568
Masaoka classification of 630
Thyroid
disorders 231
function 615
tests 591
hormone replacement therapy 11
profile 525
Thyrotoxicosis 231
Tiagabine 264, 405
Tics 342, 343, 409, 428
classification of 428, 428t
disorder 281, 428
classification of 428
secondary 429
epidemiology of 428
functional 411
management of 430
neurological complications of 424
status 424
syndrome 427
Tissue
peripheral 823f
plasminogen activator 136
recombinant 127
transglutaminase 373
type plasminogen activator 127
Tizanidine 29, 405, 803
Tobramycin 865
Todd's palsy 242
Tolazoline hydrochloride 11
Tolbutamide 868
Tolosa-Hunt syndrome 16
Toluene 474, 752, 774, 776
Tongue abnormality 385f
Tonic
activity, unilateral 240
clonic seizures 173, 206, 207
pupils 620
Topiramate 21, 29, 65, 211, 227, 264
Tourette's syndrome 427429
Toxic
encephalopathy 760, 761t
acute 764
chronic 761, 762t, 764
pathophysiology of 760
leukoencephalopathy 463, 471, 474t, 478
myelopathy 766, 766t, 767f, 768t, 785
myopathy 781, 785
neurological disorder 749
neuropathies 725, 774, 775, 779
Toxoplasma 577, 822
Toxoplasmosis 232, 233f, 849
Traditional aphasia syndromes 508f
Trail making test 495
Tramadol 380, 867
Transaminase, serum 65
Transcortical
motor 508
aphasia 547
sensory 508
aphasia 547
Transcranial
direct current stimulation 512, 873, 874
magnetic stimulation 21, 413, 674, 874
repetitive 512
Transcutaneous electrical nerve stimulation 332
Transcutaneous vagal nerve stimulation 22
Transdermal patch 828
mechanism 828f
Transforming growth factor 190
Transient global amnesia 179, 182, 214
Transient ischemic attack 49, 119, 124, 148, 179, 180, 184, 214, 396
Transmission electron microscopy 727
Transporter hypothesis 188, 188f
Trauma 141, 396
Traumatic injury 49, 51
mild 49
moderate 49
severe 49
Tremor 65, 284, 326, 342344, 353, 359, 409
classifications 353
essential 280, 287, 353
functional 410
psychogenic 355
syndromes 353
epidemiology 353
Triazoles 105
Trichloroethylene 752, 774, 776
Tricyclic antidepressant 29, 302, 379, 383, 867
Trifluoperazine 865
Triflupromazine 384
Trigeminal autonomic cephalalgias 4, 6, 14, 15, 31, 32, 32f, 40
classification of 31
subtypes of 34t
Trigeminal nerve compression 42
Trigeminal neuralgia 7, 16, 6365, 486
idiopathic 64
secondary 64
painful 63
Trigeminal sensory
loss 589
neuropathy, progressive 486
Trigemino-cervical complex 41f
Trihexyphenidyl 300
Trimethoprim-sulfamethoxazole 75, 76
Triorthocresyl phosphate 605, 766, 768
poisoning 769
Triptans 19
Trochleitis 56
Trophy sign 646
Tuberculoma 78, 80, 83t, 85
caseating 83
stage of 83
Tuberculosis 78, 232, 482, 516, 564, 792
disseminated 78
intracranial 78
miliary 78
spinal 78, 86f
Tuberculous meningitis, complications of 80
Tuberous sclerosis 203, 204b, 396,
Tuberous sclerosis complex 190, 203
Tumor 41, 826
disorders 26
necrosis factor 525
antagonists 612
Typical distal symmetric polyneuropathy 602
U
Ubiquitin-proteasome system 685
Udd's myopathy 640, 651
Ullrich congenital muscular dystrophy 648, 715f
Ulrich myopathy 638
United Kingdom Parkinson's Disease Society Brain Bank Criteria 287
Unverricht-Lundborg disease 207
Upper motor neuron 672, 673, 681, 683
syndrome 797, 799
Urea cycle
disorders 573
metabolism 579t
Uremia 334, 516
Uric acid 278
Uridine-diphosphate-glucuronosyltransferase 221
Urinary
dysfunction 299, 303
incontinence 312
retention 65
tract infections 137
urge 237
Urine 570
analysis 570
organic acid 661
tests 126, 755
Uveitis, severe 486
V
Vacuolar myopathies, types of 720t
Vagal nerve stimulation 254, 257
Valley sign 643f
Valproate 65, 211, 264, 405, 781
Valsalva maneuver 10
Vancomycin 75, 76
Varicella zoster 448, 577, 603
Varicose veins 378
Vascular
artery syndromes 486
cognitive disorder 532, 547
dementia 515, 516, 519, 545, 546, 684
subcortical 532
disease 232, 475, 564
encephalopathy 763
endothelial growth factor 615
parkinsonism 287, 342
Vasculitis 147, 232, 478, 482, 577, 725
profile 591
tuberculous 80
Vasculopathy, tuberculous 78
Vasoconstriction, peripheral 21
Vasovagal syncope 214
Vector systems, design of 825
Venereal disease research laboratory 570
Venlafaxin 65
Venous sinus thrombosis
erebral 4
septic 72
Ventricular drainage 132
Veralipride 384
Verapamil 867
Vertigo 184
peripheral 179
Vigabatrin 211, 227, 265, 474
Vinca alkaloids 752
Vincristine 590, 606, 779, 784, 868
Vinyl chloride 774
Viral
demyelination 442
diagnosis 90
diseases 577
encephalitis 482
integration 818
meningitis 56
meningoencephalitis 335
Vision loss 83f
Visual
cortex, primary 505
disturbances 862
evoked potential 445, 756
hallucinations 315, 562
loss 449
persistent complete 486
severe 486
memory 548
neglect 547
orthographic analysis 510
Visual Analog Scale 32, 38
Visuospatial dysfunction 120
Vitamin
deficiency 469, 482
serum 591
D
deficiency 27, 444
supplementation 446
deficiency 373, 516, 590, 622
E 590
deficiency 372, 376, 594
K 133
supplementation 220
Voltage-gated calcium channel 377
Vomiting 79
cyclical 15
von Eulenberg's disease 639
Voriconazole 105
W
Waldenstrom's disease 590
Walker-Warburg syndrome 649
Wallenberg syndrome 486
Wechsler's memory test 493
Wegener's granulomatosis 231
Welander myopathy 651
Werdnig-Hoffman disease 696
Wernicke's aphasia 508, 511, 547
Wernicke's encephalopathy 463, 468, 468f, 469f, 478, 479, 570
Wernicke-Korsakoff encephalopathy 750
West nile virus 448, 603
infection 603
West syndrome 173, 202, 203, 211, 226
classification of 203
Whipple's disease 482, 564, 567
White matter
hyperintensity 373
periventricular 475, 506
subcortical 676f
Williams myopathy 651
Wilson's disease 324f, 226, 280, 319, 320, 321t, 322, 322t, 325, 326t, 327, 333, 334, 370, 424, 516, 573, 574
mutations 320t
Wing-beating tremor 355
Withdrawal emergent syndrome 385
Wound
dehiscence 726
infections, minor 726
X
Xanthomatosis, cerebello-tendineous 376
Xeomin 363
Xerostomia 65
Xylene 774
Y
Young-onset dementia 573
Z
Ziehl-Neelsen stain 81, 726
Zika virus 603
Zinc
finger protein 377
myelopathy 766, 768, 772
therapy 325
Ziprasidone 384
Zolmitriptan 20, 228, 265
Zonisamide 211
×
Chapter Notes

Save Clear


1Headache
Section Editor
Debashish Chowdhury2

Approach to a Headache PatientCHAPTER 1

Debashish Chowdhury
 
INTRODUCTION
Headache is a very common complaint. Approximately 90% or more of the general population report a lifetime history of headache.1 It has been estimated that 1-year prevalence of headache in Karnataka state of India is 64%.2 Hence, it is commonly encountered in routine clinical practice. People seek medical attention when their headaches become recurrent and disabling or present as an acute catastrophic event. It becomes challenging for the physicians to make sense of headache as a complaint and arrive at a diagnosis. The causes of headache are many and until and unless these patients are evaluated with a systematic and structured approach, the underlying conditions may remain elusive. Hence, in the following sections, the principles of approach to a headache patient are discussed from a practical framework.
 
OBJECTIVES OF HEADACHE EVALUATION
As stated earlier, the approach to a headache patient may be challenging because there are more than 300 causes to consider which may overwhelm the logical thinking process. It is always better to start with five basic questions. These are:
  1. Is it a sinister headache? (Is it a potentially life-threatening headache? If yes, what will be my immediate action plan?)
  2. Is it a primary headache? (Have I ruled out common secondary causes?)
  3. If yes, what is the type of primary headache? (Do the headache features fulfill the clinical criteria of one of the primary headaches?)
  4. What subtype is it? (Episodic, frequent, infrequent, chronic, complicated)
  5. What is its impact on patient's life? (Especially in frequent and chronic headache patients)
 
GENERAL POINTS ABOUT RULING OUT A SECONDARY HEADACHE
When a headache patient visits a physician for the first time, one of the chief concerns is not to miss a secondary cause of headache. The International Classification of Headache Disorders, 3rd edition (beta version) (ICHD-3β) also classifies headache disorders into two groups, namely:
  1. Primary headaches
  2. Secondary headaches.
Further, at the end of defining criteria of each primary group in ICHD-3β, it is mandated that all possible secondary causes need to be ruled out.3 There are no biological markers for primary headaches. To make the matters worse, primary headaches are much more common than secondary headaches. Therefore, in the clinic, the physician has to look for secondary headaches (which are uncommon) from a large group of patients with primary headaches (which are common). Thus, it becomes challenging to make sure that one is not missing a hidden secondary cause when one is diagnosing a primary headache. However, since headache is such a common problem, it is neither possible nor cost-effective to screen all patients of headache with imaging or other investigations. Hence, certain clinical red flags have been identified which if present suggest the possibility of secondary headaches. Patients with red flags should be subjected to investigations. Physicians dealing with headache patients must therefore be familiar with these red flags. Red flags may be remembered by a mnemonic (for example, SNOOP4 given by Professor David Dodick).4 Other way is to remember three key elements in headache diagnosis namely onset and progression, certain headache characteristics, and headache associations (OCA, Table 1). Certain historical features can be reassuring for the diagnosis of a primary headache. These include onset in adolescence and early adulthood, a stable phenotype over a long period of time, positive family history of a primary headache (like migraine), strong association with menstruation, and side shifting headaches (in case of migraine).4
TABLE 1   Red flags (warning symptoms and signs) for secondary headaches
Basis
Common secondary etiologies
O
Based on headache onset and temporal profile
1.
First worst or very severe headache ever
SAH, RCVS, dissection, CVT, pituitary apoplexy, bleeding into a tumor, intracranial bleed
2.
Subacute onset with progressive worsening (days to weeks)
Intracranial space occupying lesions
3.
New onset headache in adult life >50 years
Intracranial space occupying lesions, temporal arteritis, primary CNS angiitis, metastasis
C
Based on headache characteristics
4.
Vomiting preceding headache
Intracranial space occupying lesions
5.
Headache associated with exclusive or predominant nocturnal occurrence or early morning awakening
Intracranial space occupying lesions causing raised ICP
6.
Headache precipitated by cough, sneeze or straining, sexual activity
CV junction anomalies, posterior fossa SOLs, SAH, RCVS
7.
Exclusive orthostatic headaches
Intracranial hypotension
8.
Recent change in character/”frequency”
Medication overuse headache
9.
Exclusive side-locked migraine like headaches
AVMs, tumors
10.
Side-locked + CAS (TACs phenotype)
Posterior fossa tumors, pituitary tumors, AVMs, metastasis
A
Based on headache associations
11.
Headache associated with abnormal neurological examination
Multiple causes
12.
Fever or other unexplained systemic signs
CNS infections
13.
Known systemic illness (e.g., cancer, HIV)
Opportunistic CNS infections, metastasis
14.
New onset headache in pregnancy
Preeclampsia, CVT, RCVS, SAH, pituitary apoplexy
SAH, subarachnoid hemorrhage; RCVS, reversible cerebral vasoconstriction syndrome; CVT, cerebral venous thrombosis; CNS, central nervous system; ICP, intracranial pressure; CAS, cranial autonomic symptom; TACs, trigeminal autonomic cephalalgias; HIV, human immunodeficiency virus; CV junction, craniovertebral junction, SOLs, space occupying lesions; AVMs, arteriovenous malformations; CVT, cerebral venous thrombosis.
 
PRACTICAL FRAMEWORK OF THE APPROACH TO A HEADACHE PATIENT
It is important to know how to frame your questions to get your diagnosis. Headache patients may present to the emergency department (ED) or in the outpatient clinic. The approaches are slightly different and hence discussed separately.
 
Patient Presenting in Emergency Department
When did this headache start? Did you have previous history of such headaches? These are the first questions to be asked. If the patient says that she had similar episodes of such headaches in the past, possibility of an acute attack of a primary headaches exits and needs to be characterized further. It may be possible that even this particular attack may be of secondary cause. Hence, questions regarding red flags need to be asked even if there is previous history of primary headaches. All patients with a thunderclap headache (TCH) presentation, that is, sudden onset headache reaching maximal intensity instantaneously must be evaluated for a secondary cause (Box 1). Up to 25% will turn out to be subarachnoid hemorrhage. Any first attack of worst headache ever, even though not fulfilling TCH criteria (that is, attaining maximum intensity within 1 min), must also be evaluated for a secondary cause. Additionally, history of fever, generalized malaise and weight loss, seizures, jaw claudication, recent exposure to toxins or drugs, recent head trauma, substance abuse or its withdrawal, history of symptoms related neck, eyes, ears, nose, sinuses, teeth, mouth, or other facial or cervical structure must be taken. Sometimes, myocardial ischemia can present as acute severe headaches. History of previous exertion headaches in an elderly or ischemic heart disease may be useful.
5Occasionally, psychiatric patients present with acute headaches in ED. However, headaches attributable to a psychiatric disorder should only be considered after exclusion of other causes.
Certain points in general and systemic examination are important to note. Vital parameters should be assessed for elevated blood pressure, pulse rate, and temperature. An elevated blood pressure is often the result and not the causative factor of severe headache. However, if blood pressure is more than 180/120 mmHg, possibility of hypertensive crisis with or without encephalopathy must be entertained. Conditions like intracranial hemorrhage, infarction, subarachnoid hemorrhage, posterior reversible encephalopathy syndrome, and reversible cerebral vasoconstriction syndrome (RCVS) may be entertained. Uncommon causes for hypertension-related headaches include pheochromocytoma and autonomic dysreflexia in patients with spinal cord injury. General physical examination should include skin (for rash), head, and neck (for sinus tenderness, conjunctival injection, temporal artery tenderness, bruit, and enlarged lymph nodes).
Patients presenting in ED with headache and focal or global neurological deficits will invariably have a secondary cause. Hence, it is relatively easy to provisionally diagnose these patients as secondary headache and go ahead with appropriate investigations. For example, an acute headache presenting with focal deficit like hemiplegia in an uncontrolled hypertensive patient may suggest a diagnosis of intracranial hemorrhage and an urgent plain computed tomography scan of cranium will clinch the diagnosis. However, the signs may be subtle during the initial phase of a disease and hence, may be missed. For example, a patient presenting with acute onset hemicranial headache and neck pain may not have much clinical signs except subtle painful Horner's syndrome and hence, the diagnosis of carotid dissection might be totally missed. Essentially, the clinical challenge lies in detection of soft signs. Any subtle deficits on examination assume importance to correctly proceed toward a diagnosis of secondary headache.
 
Patient Presenting in Clinic
For patients presenting in the clinic, the evaluation should proceed in a systematic manner as follows:
 
Onset and Temporal Course
Headache onset and course provides very important clues for headache diagnosis. Based on this, headaches can be broadly classified into three groups, namely
  1. Acute new onset headaches
  2. Episodic recurrent headaches
  3. Chronic headaches.
Acute new onset headaches such as TCH have been discussed in the previous section. Primary headaches with acute de novo onset may also occur but difficult to diagnose unless secondary causes are ruled out. Most of the primary headaches begin insidiously and follow a pattern of recurrence with ups and downs in frequency. Three common primary headaches are tension-type headache (TTH), migraine, and cluster headache (CH) (Table 2). Tension-type headache is a relatively featureless headache with patients complaining headaches (or heaviness), usually mild, dull, and pressing type, usually holocranial with absence of systemic features like nausea and/or vomiting, photophobia, and phonophobia. Patients do not have motion sensitivity and, therefore, can move around and work despite the headache. The duration varies widely from 30 minutes to 7 days. Most of them do not present to the clinic. In contrast, chronic TTH (CTTH) patients may present to the clinic. Typically, CTTH patients have long history of daily or near daily headaches and are poorly responsive to treatments. Despite this, most of them are able to carry out their day-to-day work. Many of these patients have psychiatric comorbidities and some have pericranial tenderness.
The most common headache seen in the clinic is migraine. Migraine patients have recurrent, episodic, long-lasting hemicranial or holocranial headaches, throbbing or bursting in character, usually moderate to severe in intensity that inhibits or prohibits work, builds up slowly and abates slowly, some preceded by aura and associated with nausea and/or vomiting, photophobia, phonophobia, and motion sensitivity (aggravation of headache due to movements and hence preference to lie down quietly). Onset is usually in adolescence or early young age. A common reason for presentation in the clinic is worsening over past few months to years. The clinician should try to analyze the reasons for the worsening. The usual causes include stress, family conflicts, bereavement in the family, change in job, and study pressures. Triggers strongly influence the occurrence of migraine attacks. Sometimes, the attacks become frequent especially due to persistence of triggers like stress or sleep deprivation. In up to 3% of the patients, episodic migraine headaches can transform into a chronic state leading to chronic migraine. Many such chronic migraine patients abuse acute pain medications such as analgesics, triptans, ergots or opioids, and thus also have medication overuse headache (MOH). ICHD-3β allows both the diagnoses in such patients.3 To diagnose MOH, information about the duration, nature, and frequency of drug(s) abused is important. Chronic migraine patients may lack typical characteristics of migraine in many of their attack days and the headaches may have the phenotype of TTH.
6
TABLE 2   Comparison of three common primary headaches
Features
Migraine
Tension-type headache
Cluster headache
Duration
4–72 h
30 min to 7 days
15–180 min
Frequency
Variable; in acute type, 1–14 days/month; in chronic type, more than 15 days/month
Variable; in acute type, 1–14 days/month; in chronic type, more than 15 days/month
1–8/day; clustering
Pain
Mild, moderate, severe
Mild to moderate
Severe
Character of pain
Throbbing, pulsatile
Pressing, tightening; band-like
No specific character defined by ICHD; piercing, stabbing or gnawing
Laterality
Hemicranial in 60%; holocranial in 40%
Usually bilateral
Unilateral and side-locked in 85%
Location
Any part of head can be affected
Usually frontal; may occur in other areas
Characteristically involves V1 distribution (periorbital, frontal, and temporal)
Build-up
Fast or slow
Slow; remains almost the same throughout the day; increases during the evening time
Very fast
Cessation
Gradual, general malaise, exhaustion persists (postdrome)
Gradual but no postdrome
Abrupt
Cranial autonomic features
May be seen in 50%; usually bilateral
None
Prominent; ipsilateral to the side of headache
Systemic complaints
Nausea and/or vomiting; photophobia, phonophobia, osmophobia; motion sensitivity (patient wants to lie still)
No nausea/vomiting; either photophobia or phonophobia, never both; some may have pericranial tenderness; activity not affected
Nausea/vomiting uncommon; photophobia and phonophobia when occurs may be lateralized ipsilateral to headache
Patient disposition
Vegetative
Normal
Restlessness and agitation
Gender
Female predominant
Female predominant (slightly)
Male predominant
ICHD, International Classification of Headache Disorders.
TABLE 3   Risk factors for chronification of migraine
Not readily modifiable
Modifiable
Putative, currently being investigated
Age/female sex
  • Increasing attack frequency
  • Allodynia
Low education/socioeconomic status
  • Obesity
  • Medication overuse
  • Stressful life events
  • Proinflammatory states
  • Prothrombotic states
Head injury
  • Caffeine overuse
  • Snoring
  • Other pain syndromes
  • Specific genes
However, when asked in detail, at least some days still retain the migraine phenotypic features. ICHD-3β requires presence of at least 8 such days to make chronic migraine diagnosis.3 Certain risk factors for chronification have been identified. These need to be identified as some of them are modifiable (Table 3).5 Chronic migraine along with CTTH are the two common forms of long duration primary chronic daily headaches. The other two, namely, new daily persistent headache and hemicrania continua (HC) are uncommon. The differential features are tabulated in Table 4.
The third common type of headache seen in clinic is CH, the first disorder grouped under trigeminal autonomic cephalalgias (TACs). Cluster headache has short-lasting side-locked unilateral severe headaches with prominent ipsilateral cranial autonomic symptoms/signs (CAS) and restlessness. The headaches usually peak early within minutes and abate abruptly as they had begun. In typical cases, the phenotype is distinct. Acute onset with episodic 1–8/day short duration attacks with circadian periodicity suggests the diagnosis. History of clustering of such attacks around weeks/months clinches the diagnosis. Chronic subtype with daily attacks without remission is uncommon. In contrast, the other headache in this group, namely, paroxysmal hemicrania (PH) with similar clinical features occurs more commonly in chronic form and is distinguished from cluster by the brevity of attack duration and greater number of attacks per day.7
TABLE 4   Differential diagnosis of long duration primary chronic daily headaches
Chronic migraine
Chronic tension-type headache
New daily persistent headache
Hemicrania continua
≥15 days of headache/month for more than 3 months out of which at least 8 days should fulfill migraine headache criteria as per ICHD-3β; rest of the days can have either migraine or TTH; coexistence of medication overuse allowed; coexistent diagnosis of TTH not allowed because it is within the diagnosis of chronic migraine
≥15 days of headache/month for more than 3 months; headache should fulfill criteria of TTH as per ICHD-3β; should not have more than 8 days of headaches fulfilling migraine criteria as per ICHD-3β; if so, diagnosis of chronic migraine should be given
Headache daily from its onset for more than 3 months; onset is clearly remembered and the headache is continuous within 24 h of onset
Persistent headache for more than 3 months; unilateral; usually mild background pain with moderate or severe exacerbations; either/or presence of at least one ipsilateral cranial autonomic symptoms/signs and restlessness; absolute response to therapeutic doses of indomethacin
ICHD-3β, International Classification of Headache Disorders, 3rd edition (beta version); TTH, tension-type headache.
 
Headache Characteristics
 
Attack duration
An important key feature in headache diagnosis is based on duration of an individual attack. The ICHD-3β differentiates primary headaches based on attack duration3 and these have been broadly divided into two groups, namely:
  1. Long duration headaches
  2. Short duration headaches.
Migraine headaches are long duration headaches (4–72 hours), whereas TACs are short duration headaches lasting for minutes to 3 hours. There are headaches which can last from seconds to few minutes, examples being short-lasting unilateral neuralgiform headache attacks (SUNHA), trigeminal neuralgia (TN), and stabbing headaches. Although, in clinical practice, some overlaps are common, if most of the headache episodes have attack duration within a defined category, it becomes much easier to narrow down the differentials. In chronic headaches, the number of attack days should be noted along with the duration of exacerbations, if any.
 
Attack Frequency
Based on attack frequency, headaches are classified into two groups:
  1. Episodic (low or medium frequency headaches occurring less than 15 days in a month)
  2. High frequency (headaches occurring more than 15 days in a month).
Although arbitrary, this distinction is useful as it leads to different differentials. Together with information about attack duration, it can lead to a practical diagnostic algorithm for primary headaches (Flowchart 1).6 For all primary headaches, ICHD-3β requires presence of certain minimum number of attacks for the diagnosis. It is important to note that attack frequency is also important to categorize headaches as episodic or chronic. Also, subtyping of the TACs group is based on number of attacks per day.3 As one move from CH to PH and SUNHA, the duration becomes less and less but the attack frequency/day becomes more and more (see the chapter on Trigeminal Autonomic Cephalalgias).
 
Time to Peak
While there is usually a slow build up in migraine, CH and PH have a very rapid peaking within minutes. Tension-type headache patients usually have more or less same intensity of headache with occasional increase especially during evening hours after work. Information about time to peak has a bearing on treatment as well. For example, some migraine patients may have rapid peaking; if present, such patients should be advised a rapidly acting triptan such as subcutaneous sumatriptan to abort their attacks.
 
Time of the Day
In general, headaches can occur at any time. Some headaches have predilections for nocturnal occurrence. Classic examples include hypnic headache (HH) and CH. In HH, attacks tend to occur every time at a same time of the night (usually 2–3 hours after the onset of sleep) and hence, the name “alarm clock headaches”. In CH, the attacks may also be fixed at particular times of the day or night. Daytime naps are known triggers for CH. Early morning headaches are seen in secondary headaches due to raised intracranial pressure (ICP) and headaches secondary to sleep apnea. Some migraine patients can also complain of headaches upon awakening.
 
Time of the Year
Cluster headache may display circumannual periodicity in addition to circadian periodicity. The cluster periods lasting for weeks to months tend to occur in certain months/seasons of the year. Occasionally, migraine patients may also show cyclical patterns (cyclical migraine).8
zoom view
FLOWCHART 1: Diagnostic algorithm for primary headaches.
 
Location and Laterality
Location of pain may provide useful clues. Trigeminal autonomic cephalalgias are usually unilateral and side-locked pain predominantly affecting V1 distribution. Characteristically, the maximum pain intensity occurs in and around the eye. In 15% patients, the headaches change sides, either within (rarely) or between the cluster periods. Most of the patients complain the pain maximally at orbital, retro-orbital, and periorbital areas. Migraine headaches can be hemicranial or holocranial. In many, hemicranial headaches may progress to involve the entire head. However, more importantly, even in those with hemicranial headaches, side changes from bout to bout. Side-locked migraine occurs in around 15–20% of patients and is a relative red flag. Tension-type headaches are usually band-like and bilateral. In neuralgias, the pain usually radiates to another region depending upon the distribution of the nerve. For example, in TN, the pain primarily involves V2, V3, and V1 distribution. Isolated V1 distribution of pain in TN occurs rarely and alternate diagnosis such as SUNHA may be considered. Pain and tenderness along temporal artery may suggest temporal arteritis. Headache due to raised intracranial tension usually occurs in bifrontal and bioccipital areas.
 
Pain Character
This is the most difficult part in evaluation as people use different expressions to describe the character of their pain. Some cannot describe them at all and insist only on severity. Migraine pain is usually described as throbbing or bursting, whereas TTH pain is described as heaviness, pressing, or band-like. Trigeminal autonomic 9cephalalgias patients describe the pain as boring, piercing, electric current-like, burning or bursting. It is noteworthy that because of these variable expressions, ICHD-3β has not defined any character of pain in TACs in contrast to migraine and TTH.
 
Severity
Although occurrence of recurrent severe pain brings the patient to the doctor, in terms of differential diagnosis, assessment of headache severity is not very useful. Tension-type headache is usually described as mild whereas migraine patients have moderate to severe and TAC patients have extremely severe headaches. However, these complaints may vary widely between the groups and also from attack to attack. However, assessment of severity is important for stratification of patients in migraine to select the right options of abortive medications. Severity is also important to define the TCH in ED. Change in headache severity has also been taken as an outcome parameter to study the efficacy of a drug.
 
Associated Symptoms and Signs
Most often, headache history revolves around headache phase. But it is also important to know what happens before and after the headache phase. Hence, these are described separately.
 
Before the Headache
Many migraine patients have premonitory symptoms before the onset of a clinical attack. These are important to ask because it has been found that 72% patients correctly predicted migraine onset from their premonitory symptoms when evaluated by a prospective electronic-based diary.7 Three most common premonitory symptoms are feeling tired and weary, having difficulty in concentrating, and stiff neck. About 20–25% patients report transient focal neurological deficits in the form of aura in migraine.8 Aura has been less commonly reported from Indian subcontinent. Visual aura is the most common followed by sensory and language aura. Patients with hemiplegic migraine, a rare disorder, may have motor aura. Aura has also been described in CH. Clinically, visual aura in migraine is characterized by four features, namely:
  1. Slow evolution and lasting over 20–30 minutes
  2. Occurrence in hemifield distribution
  3. Positive phenomenon (like scintillations and fortification spectra) followed by enlarging negative phenomenon (like scotomas)
  4. Disappearance of the symptoms in the same order as that of beginning.
Close differentials include epilepsy in children and young adults and transient ischemic attack in elderly. In retinal migraine, a rare condition, the patients complain of visual loss in monocular distribution.
 
During the Headache
Three questions regarding associated symptoms and signs are important to ask during the headache phase:
  1. Systemic complaints: Important symptoms during the headache phase are presence of photophobia, phonophobia, osmophobia, nausea, and vomiting. These should be routinely asked. Among these, nausea and phonophobia are the most common complaints in migraine. It should be noted that all these symptoms may not be preset in all the attacks. Secondly, although classically seen in migraine, these may also be seen in TACs, although in lesser frequency and in much less florid manifestations. Notably, when present in TACs, they are commonly reported lateralized to symptomatic side in contrast to migraine where they are usually bilateral. Tension-type headache patients usually do not report such systemic complaints and hence their headaches are often “featureless”.
  2. Behavior during the attack: Migraine patients have motion sensitivity. Routine physical activities increase their headaches. Hence, they prefer to limit their movements by lying down or resting in a dark quiet room (to avoid photo- and phonophobia). However, these manifestations depend on severity of the attack, social context, and environment. In contrast to migraine, TAC patients have both motor and behavioral restless during the headache. They usually cannot sit still and tend to perform various activities like pacing around, running, pressing their head repetitively, banging their head, immersing their face in hot or cold water, crying, and shouting. This characteristic feature of “restlessness” has now been included as a diagnostic feature of CH in ICHD-3β.3
  3. Cranial autonomic symptoms and signs: Ipsilateral cranial autonomic symptoms and signs are the hallmarks of TACs. These include seven features, namely:
    • Conjunctival injection and/or lacrimation
    • Eyelid edema
    • Forehead and facial sweating
    • Nasal congestion and/or rhinorrhea
    • Sensation of fullness in the ear
    • Forehead and facial flushing
    • Miosis and/or ptosis.
Presence or absence of these symptoms must be asked routinely to all headache patients. It is important to note that aural fullness has been recently included as a CAS in ICHD-3β.3 Presence of even a single CAS can be taken as a diagnostic criterion in TACs. Some of these features may also occur bilaterally in TACs despite the headache occurring unilaterally; however, bilateral CASs are more common in migraine and can be seen in up to 50% of patients.910
TABLE 5   Triggers for three common primary headaches
Migraine
Cluster headache
Tension-type headache
  • Stress and mental tension
  • Dietary factors: Most common are chocolate, dairy food like cheese, citrus fruit, fried fatty food
  • Menstruation
  • Missing meals
  • Alcohol (especially red wine)
  • Over and under-sleeping
  • Tiredness and fatigue
  • Change in weather
  • Bright light, glare, flickering light
  • Exertion
  • High altitude
  • Hair wash
  • Caffeine
  • Monosodium glutamate
  • Small amount of alcohol during cluster period; large amount may paradoxically be protective
  • Change in ambient temperature (hot)
  • Emotional stress
  • Over and under-sleeping (daytime naps)
  • Odors of paints and solvents
  • Relaxation
  • Smoking
  • Fatigue
  • Altitude
  • Menstruation
  • Flashing lights
  • Histamine and nitroglycerin
  • Stress and mental tension
  • Lack of sleep
  • Tiredness and fatigue
  • Missing meals
 
After the Headache
Many migraine patients complain of fatigue and lack of concentration even after their headaches are over. This may persist for hours and has been called as postdrome. In contrast, TAC patients are usually free of postdrome; their attacks begin abruptly and end abruptly. While episodic TTH patients are usually free of any symptoms once the headaches are over, CTTH patients usually complaint an all-pervasive heaviness for most of the days.
 
Triggers
Migraine gets precipitated by well-known triggers and it is important to ask them. They aid in diagnosis. Triggers, if avoided, can lead to significant decrease in the frequency of headache episodes; however, not all can be avoided. Some patients are well aware of their triggers and try to avoid them before they seek consultation. Some, however, are oblivious of the “concept” of triggers. Once identified by them, they can be instructed to avoid at least some of them and thus avoid the precipitation of headaches. Common triggers in three common primary headaches are shown in Table 5.
Besides these three primary headaches, there are a group of uncommon primary headaches wherein many entities are characterized and defined by their association with a precipitating factor. Examples include cough (Valsalva maneuver)-induced headaches, exercise-induced headaches, and headaches associated with sexual activity. It is important to note that similar presentations can also be seen in secondary etiologies. Other headaches in this group are described by assuming cause and effect relationship. Examples are cold stimulus headache and external pressure headache. It is also important to ask for effect of posture on headaches. Characteristically, low cerebrospinal fluid pressure headaches are promptly relieved while lying down from a sitting or standing posture. Many neuralgias and SUNHA get precipitated by cutaneous as well as activity-related triggers like talking, eating, shaving, and drinking. Characteristically, an innocuous touch or contact with strong breeze on the affected side can precipitate neuralgic pains.
 
Family History
Migraine patients have a strong family history of headaches. It is important to know because it aids in diagnosis especially in children and in others where all the defined criteria are not met. Cluster headache patients also have higher occurrence of headaches including CH in their family although the effect size seems to be small.
 
Drug History
It is very important to take drug history in primary headaches. Previous or current intake of acute and preventive medications and their efficacy are important to note. Needless to re-emphasize the fact that presence of MOH should be actively sought in chronic headaches. Response to indomethacin in adequate doses is considered as a diagnostic criterion in PH and HC. Many drugs can trigger TCHs due to RCVS such as cocaine, amphetamines, sildenafil, marijuana or marihuana, and triptans. Hence, history of such drug intake should be sought in patients suspected of RCVS. History of substances abuse and/or their withdrawal should also be taken as some secondary headaches may be caused by them (Table 6).11
TABLE 6   Headaches due to drugs, toxins, substance abuse, or substance withdrawal
Drug/toxins/substance group
Drugs/toxins/substance
Nitric oxide donor-induced headache
Amyl nitrate, erythrityl tetranitrate, pentaerythrityl tetranitrate, glyceryl trinitrate, isosorbide mono- or dinitrate, sodium nitroprusside, mannitol hexanitrate
Phosphodiesterase inhibitor-induced headache
Sildenafil, dipyridamole
Miscellaneous agents
Alcohol, monosodium glutamate, cocaine, exogenous acute pressor agent
Headache attributed to occasional use of nonheadache medication
Atropine, digitalis, disulfiram, hydralazine, imipramine, nicotine, nifedipine, nimodipine
Headache attributed to long-term use of nonheadache medication
Anabolic steroids, amiodarone, lithium carbonate, nalidixic acid, thyroid hormone replacement therapy, tetracycline and minocycline
Headache attributed to exogenous hormone
Exogenous hormones, typically for contraception or hormone replacement therapy
Headache attributed to use of or exposure to other substance
Inorganic compounds: Arsenic, borate, bromate, chlorate, copper, iodine, lead, lithium, mercury, tolazoline hydrochloride.
Organic compounds: Aniline, balsam, camphor, carbon disulfide, carbon tetrachloride, clordecone, EDTA, heptachlor, hydrogen sulfide, kerosene, long-chain alcohols, methyl alcohol, methyl bromide, methyl chloride, methyl iodine, naphthalene, organophosphorus compounds (parathion, pyrethrum)
Medication overuse headache
Ergots, triptans, NSAIDs, opiates, combinations
Withdrawal headaches
Caffeine, opioids and estrogen
EDTA, ethylenediaminetetraacetic acid; NSAIDs, nonsteroidal anti-inflammatory drug.
 
Comorbidities
 
Psychiatric
Psychiatric comorbidities such as anxiety, depression, mania, and somatization are common in headache patients. It is important to ask and characterize them as until and unless these are addressed, treating headaches alone may not be rewarding. Presence of these associated conditions may provide therapeutic opportunities in choosing a preventive medication while at times may result in limitations. For example, amitriptyline may be a good choice in patients of migraine with depression.
 
Systemic
Many somatic conditions are comorbid with migraine. Examples include bronchial asthma, atopy, and hypertension. History should incorporate such associations because these may provide both therapeutic opportunities as well as limitations when both acute and preventive medications are considered. A common example is contraindication of β-blockers like propranolol in migraine patients with bronchial asthma.
 
Personal History
Migraine is common in young women of childbearing age. Hence, history must include details of menstruation, pregnancy, and use of contraceptives. Female migraine patients (with aura) who smoke and use contraceptives are at higher risk of future vascular events.10 They need to be counseled accordingly. Many CH patients are smokers. Many have precipitation of cluster attacks during the cluster period with modest intake of alcohol. Some patients already recognize this fact and abstain during their cluster period; others need to be made aware. Repeated attacks of TCHs during sexual activity are most commonly due to RCVS. Such patients should refrain from using vasoactive drugs listed above.
 
Examination
Primary headache patients have normal neurological examination. The exception being presence of Horner's in patients with CH even after the attack during the cluster period. In some uncommon migraine subtypes, patients may develop prolonged neurological deficits. At the minimum, measurement of blood pressure, detailed optic nerve functions including fundus examination and field testing by confrontation and elicitation of subtle neurological deficits in other cranial nerves, motor, sensory, and cerebellar systems are a must in all headache patients. Pituitary tumors are notorious for escaping clinical detection as they may cause very subtle deficits initially. They can mimic migraine, tension, and CH like headaches.11
 
Diagnostic Formulation
After detailed history and examination, a diagnostic formulation must be made. Sometimes, diagnosis may 12remain provisional till certain investigations are done. However, attempts should be made to distinguish between primary and secondary headaches and answer the first four questions listed at the beginning of this chapter. It is to be noted that a patient may be having more than one type of headaches at a given time or may have past history of different types of headache. However, many patients may not be aware of this. Careful history will unravel the multiple headache types and each must be approached separately in the same sequential and structured manner. The treatment may be directed toward the dominant type.
 
Investigations
After detailed history and examination, most of the patients have clear cut features of a primary or secondary headache. Those with red flags or atypicality must be investigated. Guidelines and consensus statements of how to investigate a headache patient have been published.12 However, physicians must decide on case-to-case basis.
 
Role of Headache Diary
Headache diary is an important tool to follow-up a headache patient. It clearly shows the impact of therapy and objectively records headache characteristics. Sometimes, it may unearth existence of another headache disorder. It also gives the patient a tool to make meaningful decisions on managing their headaches.
 
Disability Assessment
Two common tools for measuring migraine disability are Headache Impact Test-6 (HIT-6) and Migraine Disability Assessment Scale (MIDAS). These give scores which indicate the degree of disability because of the headache. Treatment approaches may differ depending on how disabling the headaches are. Hence, they are important to know.
 
CONCLUSION
Approach to headache patients may seem challenging but systematic and structured approach will make the task easier. Careful and detailed history is the cornerstone for the diagnosis. Red flags in history, abnormalities detected during examination, and appropriate investigations will rule out potential secondary causes. Detailed history will also give many leads for choosing the right therapy for a patient with headache. Assessment of disability and encouraging the use of headache diaries will be rewarding for both the patient and the physician.
REFERENCES
  1. Rasmussen BK, Jensen R, Schroll M, et al. Epidemiology of headache in a general population—a prevalence study. J Clin Epidemiol. 1991;44(11):1147–57.
  1. Kulkarni GB, Rao GN, Gururaj G, et al. Headache disorders and public ill-health in India: prevalence estimates in Karnataka State. J Headache Pain. 2015;16:67.
  1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.
  1. Dodick D. Pearls: headache. Semin Neurol. 2010;30:74–81.
  1. Scher AI, Midgette LA, Lipton RB. Risk factors for headache chronification. Headache. 2008;48:16–25.
  1. Lipton RB, Silberstein SD, Dodick DW. Overview of diagnosis and classification. In: Silberstein SD, Lipton RB, Dodick DW, editors. Wolff's Headache and Other Head Pain. 8th ed. New Delhi: Oxford University Press;  2008. pp 29–43.
  1. Giffin NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology. 2003;60:935–40.
  1. Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain. 1996;119:355–61.
  1. Lai TH, Fuh JL, Wang SJ. Cranial autonomic symptoms in migraine: characteristics and comparison with cluster headache. J Neurol Neurosurg Psychiatry. 2009;80(10):1116–9.
  1. Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case control study. The World Health Organization Collaborative Study of cardiovascular disease and steroid hormone contraception. BMJ. 1999;318:13–8.
  1. Levy MJ, Matharu M, Goadsby PJ. Chronic headache and pituitary tumors. Curr Pain Headache Rep. 2008;12(1):74–8.
  1. Mitsikostas DD, Ashina M, Craven A, et al. European Headache Federation consensus on technical investigation for primary headache disorders. J Headache Pain. 2015;17:5.